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CHAPTER 1 
INTRODUCTION AND OUTLINE OF INVESTIGATION 
INTRODUCTION 
Since the p r e s e n t a t i o n of Thomas Hodgkin's c l a s s i c a l paper ' e n t i t l e d 'On 
some morbid appea rances of the absorbent g lands and s p l e e n ' , and the 
met iculous de sc r i p t i on of the pathognomonic mul t inuc lea ted g ian t c e l l s by 
Sternberg 2 in I898 and Reed 3
 l n 1902, t h i s remarkable d i s e a s e has 
cha l lenged many c l i n i c i a n s and p a t h o l o g i s t s to d i s c l o s e i t s nature and to 
contend with i t s p rev ious ly f a t a l outcome. The r e s u l t s of t h e s e i n v e s t i -
g a t i o n s , concerning the e t i o logy , pathophysiology, c l a s s i f i c a t i o n , s t ag ing 
p rocedures , and t rea tment moda l i t i e s were reviewed r e c e n t l y ^ ~ ^ . 
In t h i s mosaic of f a c e t s r e l a t i v e l y spa r se a t t e n t i o n was given to the ro le of 
the mononuclear phagocyte system in the pa thophys io logy of Hodgkin's 
d i s e a s e (HD). 
MONONUCLEAR PHAGOCYTE SYSTEM 
I t has been more than a decade s ince the concept of the mononuclear 
phagocyte system (MPS) was proposed to d e l i n e a t e the r e t i c u l o e n d o t h e l i a l 
system, which i s composed of monoblasts , promonocytes, monocytes and the 
s t r u c t u r a l l y and func t iona l ly he terogeneous t i s s u e macrophages 1 2 . This 
concept has been widely accep ted . The components of MPS d i sp lay a g rea t 
va r i e ty of func t ions 1 3 - 1 8 t They c o l l e c t the garbage of the body and are 
the re fo re involved in the debridement of wounds and the a s s imi l a t i on of 
s e n e s c e n t c e l l s . The system i s regarded as an important defense mechanism 
towards f a c u l t a t i v e and o b l i g a t e i n t r a c e l l u l a r p a r a s i t e s , such as the 
Mycobacterium Tube rcu lo s i s , L i s t e r i a Monocytogenes, Salmonella, and Leg-
i o n e l l a Pneumophilia. Another well defined funct ion i s t h e i r important 
accesso ry ro le in the induc t ion and exp re s s ion of humoral and c e l l u l a r 
immunity. A vas t burden of sec re to ry products i s found, such as enzymes, 
enzyme i n h i b i t o r s , complement components, binding p r o t e i n s , endogenous 
pyrogens , me tabo l i t e s of n u c l e i c acid metabolism, b ioac t i ve l i p i d s and 
growth f ac to r s 15,19,20 i 
Animal s t u d i e s sugges t t h a t the macrophage p lays a par t in the defens ive 
r e a c t i o n s aga ins t n e o p l a s i a . However, d i r ec t and compelling evidence , t h a t 
macrophages are important in human cancer i s not ye t a v a i l a b l e 2 1 . 
OUTLINE OF INVESTIGATION 
The f i r s t aim of the study was the i n v e s t i g a t i o n of monocyte function in HD. 
Chapter 2 comprises a review of s t u d i e s dea l ing with var ious a s p e c t s of MPS 
funct ion in HD. 
The most a c c e s s i b l e c e l l of the MPS i s the blood monocyte and there fore the 
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moat studied component. All studies in HD were performed by using either 
mononuclear leukocyte suspensions or monocytes, purified on the basis of 
their adherent properties. The first objective of our study was the 
development of a monocyte purification method, resulting in good purity and 
yield, avoiding selection and activation. A recently described counterflow-
centrifugation technique ^2 formed the basis of the new separation 
procedure. The resu l t s have been presented and discussed in chapter 3. 
As an important effector function the antibody-dependent ce l l - mediated 
cytotoxicity (ADCC) was evaluated using a DNA flow cytometric assay 2 3 . The 
resul ts in HD have been described in chapter 4. 
Whether the observed ADCC-pattern was HD-specific and/or possibly related 
with overt disease is dealt with in chapter 5. 
An alternative approach of cel l function analysis is the study of some 
aspects of cel l metabolism. The intracel lular activity of 3 enzymes of 
intermediary metabolism and 2 acid hydrolases were analysed in purified 
monocytes as well as in lymphocytes (chapter 6). 
Chapter 7 deals with the resul ts of the in vitro monocyte maturation in 
patients with HD, using two culture modalities. 
In chapter 8 some resul ts concerning the secretory capabil i t ies of these 
monocyte derived macrophages are given. 
11 
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CHAPTER 2 
HOLE OF THE MONONUCLEAR PHAGOCYTE SYSTEM IN THE PATHOPHYSIOLOGY OF 
HODGKIN'S DISEASE. 
A review of the literature 
P.H.M. de Mulder & B.E. de Pauw 
Parts of this chapter are submitted for publication in 'Blut'. 
INTRODUCTION 
One of the most s t r i k i n g f e a t u r e s in the h i s t o p a t h o l o g y of Hodgkin's d i s e a s e 
(HD) i s t h e a b s e n c e of e a s i l y r e c o g n i z a b l e malignant c e l l s , which form a 
tumor with i n v a s i v e c h a r a c t e r i s t i c s . The p i c t u r e i s dominated by c e l l s 
a p p a r e n t l y involved in tumor-host i n t e r a c t i o n s , which are more prominent in 
HD than in any o t h e r n e o p l a s t i c d i s e a s e . Despi te , or even because of, t h i s 
presumed host r e a c t i v i t y a t t h e s i t e of t h e malignant p r o c e s s , the o v e r a l l 
defence mechanisms in HD are f requent ly compromised even in t h e ear ly 
s t a g e s of the d i s e a s e '~э. 
This p e c u l i a r d i s e a s e p a t t e r n has i n s p i r e d many i n v e s t i g a t o r s t o try t o 
u n r a v e l the pathophys io logy of HD. In most s t u d i e s the r o l e of the 
lymphocyte has been t h e primary object of study . Scant a t t e n t i o n has been 
given t o t h e par t played by the mononuclear phagocyte system (MPS), n e i t h e r 
t o i t s funct ion in t h e a f ferent limb of t h e immune r e s p o n s e nor t o i t s 
e f f e c t o r c a p a b i l i t i e s . 
The purpose of t h i s paper i s to review t h e data which have been repor ted 
concern ing the funct ion of t h e MPS in HD and t h e c o n t i n u i n g controversy , 
r e g a r d i n g t h e macrophage or ig in of the supposed malignant c e l l . 
KINETICS AND DISTRIBUTION OF MONONUCLEAR PHAGOCYTES IN HD 
The MPS comprises c e l l s which are predominantly der ived from t h e gran­
ulocyte/macrophage p r o g e n i t o r c e l l in t h e bone marrow 5
 a n
d which are 
widely d i s t r i b u t e d a l l over t h e body. 
Meuret et a l . " demonstrated by means of in v i t r o 3 н - thymidine 
i n c o r p o r a t i o n s t u d i e s on bone marrow samples, a very s i g n i f i c a n t l y e leva ted 
monocyte product ion in 8 p a t i e n t s with HD, which r e t u r n e d to normal during 
long-term complete r e m i s s i o n s . In non-Hodgkm lymphomas a diminished as 
well as normal or even i n c r e a s e d monocyte product ion has been repor ted . 
Bunting was the f i r s t to d e s c r i b e an a b s o l u t e monocytosis in HD ?. In Table 1 
v a r i o u s s t u d i e s are summarized which show counts rang ing from low t o 
e l e v a t e d O , Ö - 1 0 > N 0 r e i a t i o n with s tage or a c t i v i t y of the d i s e a s e was found. 
Abnormal monocytes (up to 30$ ), often resembling Reed-Sternberg c e l l s , have 
been observed in the p e r i p h e r a l blood or in l eukocyte c o n c e n t r a t e s of some 
p a t i e n t s with HD 11-13, χ^β appearance of t h e s e c e l l s seemed t o be 
a s s o c i a t e d with f e b r i l e p e r i o d s 1 2 · 1 3 , 
Under normal c i r c u m s t a n c e s p e r i p h e r a l blood monocytes marginate 1 ^ , i . e . 
adhere a t some moment t o t h e walls of the post c a p i l l a r y venules , and then 
leave the c i r c u l a t i o n and mature to macrophages in the var ious t i s s u e s . No 
information i s a v a i l a b l e concerning the monocyte d i s a p p e a r a n c e r a t e in HD. 
There i s some e v i d e n c e i n d i c a t i n g a diminished in v i t r o y i e l d of a d h e r e n t 
monocytes from mixed mononuclear c e l l s u s p e n s i o n s 15,It^
 WhxCh might 
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Author % of p a t i e n t s with η 
monocytes<500 mn3 
Bunting 1914 100 25 
Wiseman 1936 61 31 
Levinson 1957 40 43 
Meuret 1978 50 8 
Kaplan 1980 37 100 
T a b l e 1. A b s o l u t e p e r i p h e r a l b l o o d m o n o c y t e c o u n t s i n H o d g k i n ' s d i s e a s e . 
r e f l e c t a d h e r e n c e i n v i v o . On t h e o t h e r h a n d U r b a n i t z e t a l . 1 ^ f o u n d a n o r m a l 
a d h e r e n t c e l l y i e l d , u s i n g e n r i c h e d (up t o (>2%) m o n o c y t e s u s p e n s i o n s . 
However, t h e s e s t u d i e s p r o v i d e d no d e f i n i t e a n s w e r c o n c e r n i n g m o n o c y t e 
a d h e r e n t c a p a c i t y , b e c a u s e t h e p o s s i b l e i n f l u e n c e of t h e c o n s i d e r a b l e 
l y m p h o c y t e a d m i x t u r e was n o t e v a l u a t e d . 
I n v i v o s t u d i e s of s k i n - w i n d o w m a c r o p h a g e c e l l u l a r i t y p r o v i d e d c o n f l i c t i n g 
r e s u l t s w i t h a n o r m a l c e l l a c c u m u l a t i o n i n a d u l t s ^ " a n d a d i m i n i s h e d 
a c c u m u l a t i o n i n c h i l d r e n wi th HD ' 9 , Katz 2 0 i d e n t i f i e d f e w e r m a c r o p h a g e s i n 
ЦЦ s p e c i m e n s of u n i n v o l v e d d i s a g g r e g a t e d t i s s u e s (lymph n o d e s o r s p l e e n s ) 
from p a t i e n t s w i t h HD t h a n i n n o r m a l c o n t r o l t i s s u e s . None of t h e t e c h n i q u e s 
e m p l o y e d h a v e s u p p l i e d r e l i a b l e q u a n t i t a t i v e d a t a a b o u t t h e m a c r o p h a g e 
d i s t r i b u t i o n i n s e v e r a l t i s s u e s i n HD p a t i e n t s . 
FUNCTION OF THE PERIPHERAL BLOOD MONOCYTE AND THE IN VITRO M0N0CYTE-
DERIVED MACROPHAGE 
A f f e r e n t f u n c t i o n s 
A f f e r e n t m o n o c y t e f u n c t i o n s i n t h i s s e c t i o n imply t h e i n f l u e n c e s of 
m o n o c y t e s on a n t i g e n a n d m i t o g e n i n d u c e d l y m p h o c y t e r e s p o n s e s . 
I n a few p a t i e n t s w i t h a d v a n c e d HD a n o r m a l a n t i g e n i n d u c e d r e s p o n s e was 
o b t a i n e d , when p u r i f i e d a l l o g e n e i c n o r m a l l y m p h o c y t e s were i n c u b a t e d w i t h 
p r e c u l t u r e d a d h e r e n t p a t i e n t m o n o c y t e s 1 Л T h e s e e x p e r i m e n t s wi th m a c r o ­
p h a g e s , which h a d b e e n s e l e c t e d on b a s i s of a d h e s i v e n e s s , may s u g g e s t a 
n o r m a l a n t i g e n p r e s e n t i n g f u n c t i o n o f t h e s e c e l l s . However, a n t i g e n 
p r e s e n t a t i o n i s a n l a r e s t r i c t e d f u n c t i o n a n d t h e o b s e r v e d l y m p h o c y t e 
r e s p o n s e i s t h e r e f o r e m o s t l i k e l y i n d u c e d by t h e r e m a i n i n g a u t o l o g o u s 
m o n o c y t e s i n t h e ' p u r i f i e d ' l y m p h o c y t e s u s p e n s i o n s . 
I n s e v e r a l s t u d i e s i m p a i r m e n t of m i t o g e n i n d u c e d l y m p h o c y t e t r a n s f o r m a t i o n 
was c o m p l e t e l y o r p a r t i a l l y r e v e r s e d a f t e r d e p l e t i o n of a d h e r e n t c e l l s ( i . e . 
a d h e r e n t m o n o c y t e s ) from t h e m o n o n u c l e a r c e l l (MNL) s u s p e n s i o n 2 1 - 2 7 _ if, 
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patients with a complete remission this impairment was less constantly 
observed 22-25,27_ Addition of adherent autologous monocytes resulted in a 
reinducement of the inhibition in patients with HD, at similar monocyte 
lymphocyte ratios this was not observed in normal controls. Macrophages of 
HD patients revealed no suppression on normal allogeneic lymphocytes 2 3 . 
This observation suggests an increased sensit ivi ty of HD lymphocytes for 
eventual normal monocyte suppression. This recombination study was done 
with a very limited number of patients and controls. 
In the supernatant of phytohaemagglutimn (PHA) stimulated MNL suspensions 
a fourfold higher prostaglandin-E2 (PGE2) level was found in comparison to 
normal controls . Depletion of glass adherent cel ls resulted in a 80 % 
reduction of PGEg· The supposition regarding the inhibitory role of PGEj in 
mitogen induced lymphoblastogenesis was corroborated by the observation 
that indomethacin, a eyclooxygenase inhibitor, partially restored the 
impaired transformation 21,23,24,27_ Bookman 2Ö could actually prove an 
enhanced PGEj production by 24 h adherent monocytes in HD. The in vitro 
effect of indomethacin was observed also in the mitogen stimulated MNL 
suspensions from 2 out of 4 patients after oral use of indomethacin, whereas 
th is had no effect on skin tes t responses 2 . In contrast with the earl ier 
suggested possibility of an increased sensit ivi ty of lymphocytes for 
monocyte suppression, no increased susceptibil i ty of HD lymphocytes for 
exogenous supplemented PGE2 was found " . 
Beside PGE2, hydrogen peroxide appeared to be suppressive as well 2 ' . When 
catalase, promoting the reduction of hydrogen peroxide, was added to an 
indomethacin supplemented PHA stimulated MNL suspension of HD patients, an 
additional improvement of the proliferative response was observed 2 ' . 
Despite the abrogation of these two suppressor mechanisms, a subnormal 
response s t i l l remained, once more pointing towards a lymphocyte defect as 
well. 
Twomey et al. 2 " noted a positive correlation between the percentage of 
monocytes in the MNL and the level of suppression on В and Τ cell level. 
Since the monocyte admixture in MNL obtained from HD patients is quite often 
more pronounced than in normal controls 22,26) a quantitative, more than a 
qualitative effect of monocytes may be involved. This conclusion was 
partial ly in contrast with the findings of Schechter and Soehnlen 2 2 , who 
demonstrated an equal amount of inhibition using either the original or half 
the number of monocytes in PHA driven lymphocyte blastogenesis. In favour of 
a quantitative effect was the observed relationship between a low lympho-
cyte/monocyte ratio in the peripheral blood, normally resulting in a higher 
percentage of monocytes in the MNL suspension, and the presence of 
22 suppression . 
The main objection against most of these studies is the variable composition 
of the MNL suspension due to different separation procedures. Ideally one 
should work with the purified elements (i.e. lymphocytes and monocytes) 
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recombined at a constant rat io. The fact that none of the cultures showed an 
abolishment of the mitogen induced response after depletion of adherent 
cells (monocytes), suggests that the residual monocytes s t i l l could provide 
sufficient help, since pure lymphocytes have a low proliferative response to 
mitogens ' . 
Only one study has been reported in which concanavalin-A induced 
blastogenesis was evaluated, using purified monocytes, selected by ad­
herence, and lymphocytes, at a constant monocyte / lymphocyte rat io. No 
abnormal suppression could be demonstrated on both autologous (patient) 
and normal lymphocytes, 
Also impairment of lymphocyte reactivity and transformation inducing 
capacity in mixed leukocyte cultures was found in HD " . З З - З о ^ Hillinger et 
al . З 2 reported a significantly decreased base-line response by autologous 
mitomycin treated MNL in patients with active HD as well as in patients in 
remission. Monocyte and lymphocyte mediated suppression could be de­
monstrated. In the mixed lymphocyte reactivity tes t this suppression 
appeared to be positively related with the number of monocytes , however 
for HD lymphocytes a much lower monocyte concentration seemed to be 
required than for normal lymphocytes. This was corroborated by the finding 
of an increased sensit ivity of peripheral blood lymphocytes in HD, to normal 
adherent suppressor cel l s 37. 
The severely impaired T-cell proliferation induced by irradiated ajtologous 
non-T cel ls (autologous MLC) was shown to be monocyte independent " , this 
suggests a dysfunction, a reduction of the responder T-cells 35
 o r a
 т-
cell mediated suppression. A marked stage dependent reduction of T-colony 
formation was found, coinciding with an augmented PGE? production by 
adherent monocytes, whereas inhibition of prostaglandin synthesis only 
partially restored T-colony formation 2 . 
The in several in vitro systems found suppression, as discussed above, was 
neither disease specific nor was it demonstrated in al l patients studied 
22>зі-Зо,Зо-Ц2^ Q
n e
 ghould real ize that the significance of this in vitro 
suppressor activity with regard to the etiology, cl inical course, and 
prognosis of HD is unknown. Some effects may be even art i f ic ia l due to 
laboratory bias. However, ft-om the reviewed litprature the conclusion seems 
Justified, that a subpopulation of monocytes can exert suppressive effects 
on T-cells and maybe also on В cel l activation in patients with HD. 
Furthermore it i s not excluded that an intr ins ic T-cell defect, lymphocyte 
mediated or serum factor dependent 4 3 suppression, may underly to the 
impaired T-cell proliferation in HD. 
Effector functions 
Monocyte chemotactic response and bactericidal activity were impaired in б 
out of 13 patients with advanced HD . In 5 patients with stage II HD 
19 
Author 
patients 
effector cell microorganism killing Phagocytosis Inhibition 
of growth 
Cline '70 
King '75 
14 4-9 days cultured Listeria Mono-
adherenC monocytes cytogenis 
MNL Staphylococcus 
Aureus 
f ** nd 
nd 
nd 
nd 
Steigbigel '76 29 
Leb '78 
MNL Escherichia Coli N 
Listeria Monocyto-
genis 
7 days cultured Salmonella. Listeria nd 
adherent monocytes Monocytogenis nd 
18 
ST II 5 
STIII-IV 13 
MNL 
MNL 
Escherichia Coli 
Escherichia Coli 
N 
* * 
nd 
t * + 
t * t 
nd 
nd 
nd 
N 
+ * 
nd 
nd 
Esteves '80 1 day adherent 
monocytes 
Candida 
Pseudotropicalis 
nd 
* Ρ < 0 . 0 5 
** Ρ < 0.01 
t o n l y s i g n i f i c a n t a f t e r 1,5 h i n c u b a t i o n , not a f t e r 3.5 h and 6 h. 
N = normal ; nd = not done; + = i n c r e a s e d ; * = d e c r e a s e d ; MNL - mononuclear l e u k o c y t e s . 
2. B a c t e r i a l k i l l i n g phagocytosis and growth i n h i b i t i o n by monocyte derived macrophages 
monocyte chemotactic response appeared to be normal. Kitahara et al. ^ 
found a normal mean monocyte Chemotaxis, although considerable variations 
were found. Studies concerning bacterial killing and phagocytosis by 
peripheral blood monocytes and derived macrophages are summarized in Table 
2 ЧЧ,ЧЬ-Ч9
і
 JJ0 f l n a i conclusions can be drawn. In none of the studies freshly 
purified monocytes were used, and no correction was made for the variable 
admixture of lymphocytes in the MNL. The monocyte derived macrophages were 
al l selected on basis of their adherent properties and, consequently, not 
representative for a l l circulating monocytes. Furthermore, correct quanti­
tat ive interpretation of phagocytosis and killing i s limited with the 
methods used ->0. 
Phagocytosis of IgG-coated human red blood cel ls by adherent monocytes was 
studied by Urbanitz et al. 1 ' . A significantly lower number of phagocytised 
red cells was observed in patients with advanced HD in comparison to normal 
controls. In stage II Ê patients the phagocytic capacity was enhanced 
instead of diminished. Holm et al. 31, applying a similar assay, observed a 
normal phagocytic activity in patients with HD. 
Monocyte mediated antibody-dependent cellular cytotoxicity was evaluated 
in 3 studies and was found to be diminished -' , normal ^1 and enhanced -3 as 
indicated in Table 3. Differences in target cel ls , source of antibody, 
effector cel l population and the numbers of studied patients may have 
attributed to the diversity in resul ts . 
These resul ts permit no conclusion regarding effector cel l function of 
monocytes in patients with HD. 
Metabolic aspects 
Limited information is available concerning metabolic events in monocytes 
from patients with HD. One might assume that changes in afferent and efferent 
functions are reflected in an altered metabolic activity. However, it is 
difficult to delineate the complex metabolic backgrounds of certain 
biologic functions. After activation of macrophages, inducing a great 
variety of changes in stucture and function, an enhancement of the glucose 
metabolism, especially through the hexose monophosphate shunt (HMPS), is 
one of the f irs t observed phenomena 53-55_ King et a l . " showed an 
increased glycolysis, HMPS and Krebs's cycle activity in adherent monocytes 
of patients with malignant lymphoma, including 12 patients with HD, in 
comparison to normal control monocytes. 
Nitroblue tetrazolium (NBT) reduction, normally found after phagocytosis 
5'i53
 anci reflecting the oxygen dependent oxidase activity " , was shown to 
be increased without previous stimulation in 10 patients with HD in 
comparison to normal controls . Zembala et al. -* demonstrated that 
monocytes with an increased NBT reduction after zymosan phagocytosis, 
exhibited an augmented expression of Fc-receptors and a suppressive effect 
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l\> 
Author 
patients 
target cells effector cells h 
duration 
result 
Kohl '80 HSV infected chang ADH MO 
liver cells coated 
with antiserum 
18 h 
Pehamberger ' 8 0 23 B-HRBC coated with MNL 
antiserum 
20 h 
Holm '82 0-HRBC Rh D/D ADH MO 18 h 
* Ρ < 0.02 
HSV : Herpes Simplex Virus 
HRBC: Human Red Blood C e l l s 
ADH : adherent; MO: monocytes; MNL: mononuclear l e u k o c y t e s ; Η •= hours; N - normal; + • decreased; + = increased 
Table 3. Monocyte and MNL mediated antibody-dependent c e l l u l a r c y t o t o x i c i t y 
on mitogen induced lymphocyte r e s p o n s e s . A r e l a t i o n s h i p between ' s t a t e of 
a c t i v a t i o n ' and NBT r e d u c t i o n was s u g g e s t e d . 
Chemiluminescence (CL) occurs in g r a n u l o c y t e s and monocytes a f t e r i n ­
g e s t i o n of zymosan or b a c t e r i a -'. CL product ion by monocytes was shown t o 
be s i g n i f i c a n t l y enhanced in malignant lymphoma ^ . All p a t i e n t s s t u d i e d 
were e i t h e r in complete remiss ion or r e c e i v i n g chemotherapy. CL changes 
p a r a l l e l l e d changes in t h e g lucose metabolism ^ ' . 
As d i s c u s s e d before t h e PGEj product ion was shown t o be i n c r e a s e d in 
p a t i e n t s with HD 2 1 F 2 0 . The descr ibed metabol ic e v e n t s can support t h e 
p r e s e n c e of ' a c t i v a t e d ' monocytes in HD. The mechanisms of t h i s a c t i v a t i o n 
are not unders tood; both tumor derived f a c t o r s and lymphokines 53,55
 m a
y 
play a r o l e . 
FUNCTION OF TISSUE MACROPHAGES 
The f u n c t i o n a l s tudy of t i s s u e macrophages i s g r o s s l y hampered by the 
limited a c c e s s t o t h e i r anatomical s i t e s , such as lymph nodes, sp leen and 
l i v e r . Furthermore, when in v i t r o s t u d i e s a re performed, t h e s e are only 
f e a s i b l e a f t e r complex and damaging s e p a r a t i o n procedures , i n t e r f e r i n g with 
y ie ld , funct ion, and morphology. On t h e o t h e r hand, in vivo a s s a y s , 
s e l e c t i v e l y t e s t i n g MPS function, are s c a r c e . Sheagren et a l . -'S found an 
i n c r e a s e d c l e a r a n c e of 12-> I labe led a lbumin-aggregates in 22 p a t i e n t s with 
HD, r e l a t e d t o advanced s t a g e s of t h e d i s e a s e and t h e presence of B-
symptoms. 
In a comparative study between a d h e r e n t macrophages, recovered from 
malignant ef fus ions of p a t i e n t s with HD, e p i t h e l o i d c e l l tumors, non-Hodgkin 
lymphomas and benign c o n d i t i o n s no c l e a r f u n c t i o n a l d i f fe rences were 
observed. This i n v e s t i g a t i o n included F c - and complement-receptor dens i ty 
and p h a g o c y t o s i s . A low number of pigment p a r t i c l e s in skin window 
macrophages of p a t i e n t s with HD was i n t e r p r e t e d as a diminished phagocyt ic 
c a p a c i t y ' . 
T i s s u e and plasma lysozyme might p a r t i a l l y r e f l e c t macrophage function 
^
1
·
6 2
 and in t h e absence of monocytosis i t i s a l s o r e l a t e d t o granulocyte 
t u r n o v e r " 3 . р і
а а
ш а lysozyme was s i g n i f i c a n t l y i n c r e a s e d in p a t i e n t s with HD 
in a s t a g e - and symptom-dependent manner 6 2 l t without r e l a t i o n to the 
p r e s e n c e or a b s e n c e of lysozyme in t h e l e s i o n s . 
THE HODGKIN CELL 
There i s growing e v i d e n c e t h a t the mononuclear Hodgkin c e l l and i t s b i-or 
m u l t i n u c l e a t e d c o u n t e r p a r t , t h e Reed-Sternberg c e l l , i s t h e p u t a t i v e 
malignant c e l l in HD o5,66 t T h e o r igi n 0f t h i a neoplastic cell is still the 
subject of much debate and has recently been extensively reviewed t,'*-70i j t 
is always difficult to delineate whether certain characteristics of a 
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malignant cell exclude or establish i t s commitment to a known cell lineage. 
Malignant differentiation might be accompanied by the abrogation of 
normally present characteris t ic features. Analysis of Hodgkin cel l s i s 
hampered by the difficulty of their isolation; to overcome this problem, many 
attempts have been undertaken to culture these ce l l s . Establishment of HD 
cel l- l ines appeared extremely difficult, dependent on the source of the HD 
cel ls and stage of the disease ТІ.ТЗ^ Indicating that HD cel ls have to meet 
certain unknown characterist ics before they are able to grow in vitro. 
Furthermore Harris et al. ' 2 could, using chromosome and isoenzyme 
analyses, demonstrate that several lines were not related to HD, but were 
non-human contaminants. 
Valuable information about the Reed-Sternberg cel l has been gleaned from 
cl inical observations '3,74^
 u
i t
r a
3 t
r u c
t u r a l '5-78 f immunochemical '9-ö4 ( 
histochemical 85,86i functional 8 7 , and cell culture studies 71,72,88-90, д 
Τ- cell origin seems unlikely 70,71,8,86, fhe presence of both surface bound 
and intra-cellular IgG gave r ise to the supposition of a B-cell origin "'. 
There is conflicting evidence concerning IgG being associated with free 
nbosomes and the endoplasmic reticulum 75,77, The polyclonality '7,82^ ^ g 
observed internalization of exogenous IgG °', and the lack of J-chains 
80,83,92 ¿ς,
 n o t a u p p 0 p t the B-cell hypothesis. Clinical observations 
provided evidence in favour of ' 4 and against '3 a relation with the B-
lymphocyte lineage. The presence of a B-cell antigen on the surface of 50Í 
of the cells from a HD derived cell line, demonstrated with use of the 
monoclonal antibody TU-1, would be in favour of some relation with the B-
lymphocyte lineage "f. 
There are cumulating arguments in favour of a linkage with the MPS 
71,73,76,78,79,81,82,84,87,88i
 а П ( 1 m o r e recently attention has been focussed 
on the interdigitating reticulum cell, probably related to the MPS, as a 
possible condidate 70,86,87,93,94,
 T h i g interdigitating reticulum cell has 
spiny surface projectious, irregular shaped nuclei, lacks T-cell charac­
t e r i s t i c s and is weakly acid phosphatase, and non-specific esterase 
positive. The cell is closely associated with T-lymphocytes and present in 
the thymic dependent regios of lymph nodes 94, xhey are important accessory 
cel ls in the afferent limb of the immune response. Beckstead et al. " and 
Cadin et al. 91 found a weak acid phosphatase and non specific esterase 
activity in Hodgkin's cells, and Diehl et al. 71 observed a similar pattern in 
HD derived cell l ines. Reed-Sternberg cel ls are predominantly found in the 
thymic dependent zones of lymph nodes 95^ they display interactions with T-
lymphocytes 7ö,86( t | l e n u c i e u a i3 strikingly irregular and the phagocytotic 
capacity is limited " . Moreover in a direct comparative study between Reed-
Sternberg and interdigitating reticulum cel ls , la was shown to be present on 
both cel l types and they lacked two common macrophage antigens (20.2 and 
20.3) and S'-nucleatidase 9°. in tissue biopsies and in HD derived cell lines 
this la positivity was also observed by others 71,83. 
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In a r e c e n t d e s c r i p t i o n of HD der ived c e l l l i n e s ^ a number of sur face 
a n t i g e n s normally found on immature c e l l s of t h e myeloid pathway and on 
monocytes/macrophages were shown to be p r e s e n t . Furthermore, as a r e s p o n s e 
t o a s p e c i f i c p h o r b o l - e s t e r , f u n c t i o n a l p r o p e r t i e s such a s weak phago­
c y t o s i s and a d h e r e n c e were e x p r e s s e d , s u g g e s t i n g a d i f f e r e n t i a t i o n along 
the monocytoid pathway. In a d d i t i o n , t h e s u p e r n a t a n t s of t h e s e l i n e s 
conta ined a f a c t o r capable of s u p p r e s s i o n of spontaneous c e l l mediated 
c y t o l y s i s , and colony s t imula t ing f a c t o r a c t i v i t y appeared to be p r e s e n t аз 
well. Ste in et a l . °3 demonstrated with monoclonal a n t i b o d i e s (Tii5, Tu6, Tu9) 
a l so a n t i g e n s of t h e g r a n u l o p o i e s i s on Reed-Sternberg c e l l s in fresh biopsy 
mater ia l . 
A f a s c i n a t i n g development i s t h e g e n e r a t i o n of a monoclonal ant ibody 
a g a i n s t a Reed-Sternberg c e l l determinant (K1) 93, ц 0 r e a c t i v i t y was 
observed in 50 c a s e s of non-Hodgkin lymphomas. Op t i l l now no r e a c t i v i t y has 
been found with p e r i p h e r a l blood c e l l s , s e v e r a l types of macrophages, sk in, 
l i ver , kidney, lung, or brain t i s s u e . However, a small number of normal c e l l s 
in t o n s i l s , lymph nodes and bone marrow were K1 p o s i t i v e . Using monoclonal 
a n t i b o d i e s s p e c i f i c for T - c e l l s , B- c e l l s , macrophages, d e n d r i t i c ret iculum 
c e l l s , i n t e r d i g i t a t i n g ret iculum c e l l s , c e l l s of the g r a n u l o p o i e s i s , e ry-
t h r o p o i e s i s or thrombopoies i s , no c r o s s r e a c t i v i t y could be demonstrated 
with t h e s e K1 p o s i t i v e c e l l s in normal t i s s u e . 
In conc lus ion t h e r e s t i l l i s no d e f i n i t e answer concerning the or ig in of the 
Hodgkin c e l l . Although the s t u d i e s with monoclonal a n t i b o d i e s i n c l i n e d to a 
c e l l with mono-myeloid and in a minority with B-cel l c h a r a c t e r i s t i c s , they 
did not f i t to t h e morphological and h i s t o c h e m i c a l f e a t u r e s which tended 
more towards t h e i n t e r d i g i t a t i n g re t icu lum c e l l . 
CONCLUDING REMARKS 
The major par t of t h e presented l i t e r a t u r e concerns the p e r i p h e r a l blood 
monocyte, the b e s t a c c e s s i b l e c e l l of t h e MPS, whereas MPS function i s 
predominantly d i s p l a y e d by t i s s u e macrophages. Therefore i t i s not p o s s i b l e 
to provide a ba lanced judgment concerning i t s funct ion in HD. 
The monocyte product ion was found t o be enhanced in HD, which might have 
added t o t h e often observed a b s o l u t e monocytos is . No information i s 
a v a i l a b l e in HD concerning t h e monocyte d i s a p p e a r a n c e r a t e from the 
p e r i p h e r a l blood to the t i s s u e s . The more s t a t i c r e s u l t s , such as numbers 
p r e s e n t a t a c e r t a i n time and p l a c e , allow no c o n c l u s i o n s regard ing 
turnover . 
Adequate e v a l u a t i o n s of in v i t ro funct ion of t i s s u e macrophages are due t o 
t e c h n i c a l r e a s o n s not a v a i l a b l e . The in vivo c l e a r a n c e of aggregated 
albumin i n d i c a t e s an enhanced MPS funct ion a t t h e t i s s u e l e v e l . 
The metabolic f e a t u r e s of the p e r i p h e r a l blood monocyte, such as an 
i n c r e a s e d PGE2 product ion, the augmented CL and NBT r e d u c t i o n , and the 
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enhancement of glucose metabolism indicate a stimulated s ta te . I ts nature Is 
unclear, i t can be either the expression of the presence of a younger 
population monocytes, due to a higher turnover and therefore aspecific, or 
more directly related to the tumor itself. 
The found monocyte-mediated suppression in vitro may be the expression of 
the presumed stimulation in vivo. Although monocyte mediated suppression on 
mitogen stimuled lymphocytes could be demonstrated in vitro, the s ig-
nificance for the in vivo antigen presentation and subsequent lymphocyte 
proliferation is not clarified. 
The resul ts of monocyte effector functions permit no final conclusion. 
The main objection against the reports both those dealing with afferent and 
efferent functions, i s the use of mixed cel l populations, comprising 
monocytes and lymphocytes or the use of monocytes selected on the basis of 
functional (adherent) properties. The use of purified intact cell sus-
pensions will provide more reliable data. 
The'enigma of the origin of the Reed-Sternberg and Hodgkin cell remains 
unsolved. The fact that the successfully established cell ines were often 
derived from patients with endstage disease suggests a probably more 
'malignant' character of these cells than the Hodgkin cel ls earlier in the 
disease. 
The development of the K1 antibody offers new prospects for diagnosis, 
treatment and research. 
In conclusion: no for HD specific alteration in MPS could be demonstrated so 
far. On the other hand many findings indicate an engagement of the MPS with 
probably tumor related processes and deserves therefore further study for a 
better understanding of the pathophysiology of HD. 
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CHAPTER 3 
MONOCYTE PURIFICATION WITH COUNTERFLOW CENTRIFUGATION MONITORED BY 
CONTINUOUS FLOW CYTOMETRY 
P.H.M. de Mulder, J.M.C. Weasels, D.A. Rosenbrand, J.В.J.M. 
Smeulders, D.J.Th. Wagener and С. Haanen 
Published in: Journal of Immunological Methods 1981; 47:31-38 
SUMMARY 
Continuous monitoring of cel l light scat ter during counterflow c e n t n -
fugation of a mononuclear cel l suspension allows counting and size 
recognition of the cell types elutriated. With this method an optimal 
separation point between monocytes and lymphocytes, determined for each 
individual donor, can be established. With a constant flow of 15 ml/min this 
separation point i s found at centrifugal velocit ies ranging from ЗЗ^В to 
2444 rpm (n = 10). From 50 ml venous blood, 84.1 $ t 4.1 % (15.7 t 8.6 χ 106) of 
a l l elutriated monocytes, with a purity of 92.4$ ± 1.4$, is collected in a 
volume of 50 ± 1 ml. In the same run, 92$ ± 4.3$ of the lymphocytes is 
gathered in one fraction with a purity of 98.9$ ± 0.7$. 
After counterflow centnfugation, 91.6 ± 10.5$ of the cel ls loaded is 
recovered; viability exceeds 98$. 
INTRODUCTION 
Optimal study of immunological and non-immunological functions of mono­
cytes requires purified monocyte suspensions. Conventional isolation 
techniques are based upon either their adherent properties ,>'->-\ or 
density. ^>5>ν. Monocyte isolation by counterflow centrifugation (elu-
t n a t i o n ) has recently been shown to give high purity, good recovery, and 
excellent viability and function 7,8,9,10^ Separation is based mainly on 
differences in cell size and to a much lesser extent on density. Meticulous 
regulation of flow, centrifugal force and temperature are essential to 
achieve optimal purification. After relatively 'blind' e lu tnat ion in 
fractions, screening of the effluent is usually performed by means of a 
Coulter counter. In this paper a new method is described whereby continuous 
monitoring of the elutr iator output is obtained, allowing simultaneous 
counting and size quantification. In this way it is possible to determine the 
optimal separation point between the different mononuclear cell populations 
in each elutriator procedure, resulting in improved efficiency of counter-
flow centrifugation. 
MATERIALS AND METHODS 
Collection of blood 
Approximately 50 ml venous blood from healthy volunteers, anti- coagulated 
with 6 lU/ml preservative-free heparin, is obtained by venapuncture. An 
aliquot is taken for tota l and differential cel l counting. 
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Preparation of the mononuclear cel l suspension (MNL) 
The blood is immediately diluted 3-fold with calcium- and magnesium-free 
Hank's buffered balanced salt solution (HBBS), supplemented with 100 mg di-
K-EDTA/1, final pH 7.3, 295 mosM/kg. Thirty-five ml samples are layered on 15 
ml 1.077 g/ml Ficoll-Isopaque (pH 6.6, 272 mosM/kg). After centnfugation 
(400 χ g; 30 min; 20oC) and removal of the supernatant, the interphase i s 
collected, diluted with HBBS + 0.4% bovine serum albumin w/v (BSA), washed 
once (600 χ g, 15 min, 400 and resuspended in 5-8 ml HBBS + 0.4 % BSA. A 
fixed volume is taken for counting and differentiation. The remaining cells 
are introduced into the elutriator. 
Elutnation 
Elutriation system. 
This consists of a J2-21C centrifuge equipped with the JE-6 elutriator rotor 
and standard separation chamber (Beekman Instruments, Palo Alto, CA, U.S.A.). 
The flow is maintained with a rol ler pump (Masterflex-Cole-Parmer In­
struments, Chicago, IL, U.S.A.) and pulsations are flattened by a pulse 
suppressor chamber. Medium temperature i s maintained at 10oC. The J2-21C 
centrifuge is modified by instal l ing a fine scaled speed selector (one scale 
unit: 2.6 ± 0.1 rpm) and replacing the C102 condenser (0.022 UF) by a 
condenser of 47 pF; this results in improved stabi l i ty of rotor speed. Rpm 
measurement was altered by using a high resolution counter (120 HMZ pH 6667 
Philips, Eindhoven, The Netherlands). The elutr iator effluent is collected in 
a small downflow cabinet. HBBS + 0.4$ BSA w/v is used as elutriation medium. 
Cell recognition device (Fig. 1 ). 
Continuous sampling of the elutriator output i s established by means of a T-
drain. This sample stream (a, 0.2 ml/min) mantled in a sheath stream (b, 1.4 
ml/min), is continuously analyzed for cell number and cel l light scatter by 
the electro-optical peroxidase unit of the Hemalog-D (Techmcon In­
struments Corp., Tarrytown, U.S.A.). This unit, dismantled from the Hemalog-D, 
consists of a flow cell with optical assembly for focusing the light from a 
tungsten halogen light source and an absorption and scatter photodiode. The 
light scat ter signals are accumulated and displayed on an ND-100 multi­
channel analyzer (Nuclear Data Inc., Schaumberg, IL, U.S.A.). The resulting 
histogram (fig. 2) indicates the number of cel ls as a function of cell size 
(scatter). When a new cluster of cel ls with a markedly different scatter 
signal is elutriated, a change in the histogram appears on the monitor. At 
any time the profile can be erased or stored in a memory, enabling direct 
comparison of elutriated cell populations. 
Elutriation technique. 
Prior to introduction of the cell suspension, entrapped air is removed, rotor 
speed adjusted to 2500 rpm, and medium flow established at 15 ml/rain under 
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Fig. 1. Schematic representation of elutrlator rotor (1) and the cel l 
recognition device (2), consisting of: (a) sample stream directly derived 
from elutriator effluent; (b) sheath flow; (c) ro l ler pump; (d) electro-
optical unit; (e) ND-100 multichannel analyzer. Collection of e lutr iator 
output (3). 
control of a flow-meter (Sho-rate flow-meter type No. R-2-25-B Brooks 
Instruments Inc.). By means of an infusor, the cel l sample is introduced 
directly into the tubing line at a flow- rate of 0.3 ml/min. During this period 
monocytes and larger lymphocytes remain in the separation chamber, whereas 
smaller lymphocytes, erythrocytes and thrombocytes are eluted. When 
introduction of the cel ls is completed the rotor speed is lowered 26 ± 1 rpm 
every 2 min. The decrease of centrifugal force resul t s in an outflow of 
lymphocytes with increasing diameter, while the number of cells eluted per 
time unit diminishes. At a certain rotor speed, indicated as the separation 
point, cel ls with a dist inct scatter signal (monocytes) leave the elutr iator 
(Fig. 2. profile 2). Since lymphocytes are s t i l l being washed out, a double 
peaked histogram is seen, representing the two cel l populations. The rotor 
speed is then immediately increased 15 rpm in order to wash out the 
remaining lymphocytes and to retain the monocytes. Collection of fraction 2 
i s started. When the number of cells leaving the separation chamber falls 
below 100 cells/sec, the rotor is stopped and the effluent collected in one 
50 ml tube (fraction 3). Immediately thereafter a ' res t ' fraction is gathered 
(fraction 1). After washing with HBBS + 0.4$ BSA 1(600 χ g, 15 min, 40C) the 
ce l l s are resuspended and further analysis i s performed. The whole 
procedure can be carried out within 1 h. 
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Fig. 2. Histograms as seen on the monitor of the ND-100 multichannel 
analyzer. Prior to elutriat ion: the mononuclear cell suspension. During 
elutriation: profile 1 represents lymphocytes, profile 2 represents the 
mixed population and profile 3 monocytes. After elutriat ion: scatter 
analysis of the entire lymphocyte, mixed, and monocyte population. 
39 
Cell counting and d i f f e r e n t i a t i o n 
Cel l number in t h e s t a r t i n g mater ia l , MNL and e l u t r i a t e d f r a c t i o n s i s 
measured with a Coulter c o u n t e r . Cytocentr i fuge p r e p a r a t i o n s of the MNL and 
e l u t r i a t e d f r a c t i o n s are made according to T a l s t a d and Gundersen and 
s t a i n e d with May- GrUnwald-Giemsa and n o n - s p e c i f i c e s t e r a s e , r e s p e c t i v e l y 
12,13. Dif ferent ia l count ing i s performed on 400 c e l l s . 
Cell v i a b i l i t y 
Cell v i a b i l i t y i s a s s e s s e d by two methods. (1) Ce l l s suspended in a 
c o n c e n t r a t i o n of 3-5 x 10^/ml are mixed with 20 μ 1 f l u o r e s c e i n d i - a c e t a t e / m l 
(5 mg FDA/ml acetone) and 20 μΐ ethidium broraide/ml (0.0025 mg EB/NaCL 35.8 
mg/ml and Tris 12.1 mg/ml, pH 7.5). Viable c e l l s a re FDA-positive (green 
cytoplasmic f luorescence ) and dead c e l l s ethidium bromide- p o s i t i v e (red 
DNA f l u o r e s c e n c e ) . (2) Exclusion of t rypan blue by v i a b l e c e l l s . 
RESULTS 
I f the ro tor speed i s c o n t i n u o u s l y d e c r e a s e d and t h e f low-rate maintained 
c o n s t a n t , c e l l s with a g radua l ly i n c r e a s i n g diameter wi l l leave t h e 
e l u t r i a t o r . With t h e e f f luent monitored by t h e c e l l r e c o g n i t i o n device, 
measuring l ight s c a t t e r t o a n a l y s e c e l l number and s i z e , i t i s p o s s i b l e t o 
record the d i s t r i b u t i o n of t h e s e parameters in a mononuclear c e l l s u s ­
pension (Fig. 3). In t h i s p a r t i c u l a r experiment the monitoring was s t a r t e d 
a f te r e l u t n a t i o n of the thrombocytes . The f i r s t and h i g h e s t peak r e p r e s e n t s 
the lymphocytes, t h e second c o n t a i n s t h e monocytes. This form of c e l l 
s c a t t e r r e g i s t r a t i o n al lows r e c o g n i t i o n of t h e d i f fe rent c e l l s during 
e l u t n a t i o n . The p o s s i b i l i t y of immediate i d e n t i f i c a t i o n of c e l l type 
combined with low e l u t r i a t o r output between given c e l l p o p u l a t i o n s i s the 
b a s i s of t h i s s e p a r a t i o n method. The his tograms r e g i s t e r e d during e l u ­
t n a t i o n are comparable with t h o s e of the f i n a l s e p a r a t e d f r a c t i o n s (Fig. 2). 
The r e s u l t s of 10 runs a re l i s t e d in Table 1. F r a c t i o n 3 c o n s i s t s of 
e l u t r i a t e d monocytes of high puri ty with only s l i g h t admixture of lympho­
c y t e s (6.5 ± 1.6$), some b a s o p h i l s , and very few segmented n e u t r o p h i l s . The 
majority of the lymphocytes i s p r e s e n t in t h e f i r s t f r a c t i o n with a puri ty of 
98.9 * 0.7%, with only 1.1 * 0.6$ monocytes. In t h e second f r a c t i o n a mixed 
popula t ion i s found: 2.6 ± 4.3$ of the lymphocytes and 6.2 ± 2.8$ of the 
e l u t r i a t e d monocytes. F i n a l l y a l e s s pure monocyte f r a c t i o n (80.8 * 5.6$) 
with 17.8 ± 4.5$ lymphocytes has been ga thered, r e p r e s e n t i n g only 5.5 * 3.1 
and 0.5 * 0.3$ r e s p e c t i v e l y of the t o t a l e l u t e d c e l l number. The r o t o r speed 
(rpm) at which, for t h e f i r s t time, two c e l l p o p u l a t i o n s are to be seen, i s 
defined as the s e p a r a t i o n point . This i s found a t 2392 ± 39.5 rpm with a range 
of 2348 - 2444 rpm. Viabi l i ty of the e l u t r i a t e d c e l l s i s 97.7 ± 1.1$ as 
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Fig. 3. Relationship between cel l number and light scat ter signal of 44 
consecutively elutriated fractions. Each of the 44 histograms represents 
the number and the corresponding light scat ter of the cells elutriated in 150 
sec. At the same interval the rotor speed was diminished 26 ± 1 rpm, while the 
flow remained constant at 15 ml/min. Fraction 1 is comparable to histograms 
1-29; fraction 2 to histograms 29-32; fraction 3 and 4 to histogram 32-44. 
determined by ЕВ/FDA and 98.6 t 0.5$ by trypan blue. 
After elutriat ion , 91.6 ± 10.5Í of the loaded cel ls are recovered. By the 
method described, 88.5 ± 17$ of the monocytes and 64.8 ± 9 $ of the 
lymphocytes present in the peripheral blood sample are recovered in the 
elutriator effluent, of which 72$ and 60,$ respectively are found in the 
purest fractions. The absolute number of monocytes and lymphocytes found in 
those fractions is 15.7 * 8.6 χ 10° and 63.9 ± 20 χ 10° respectively. 
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Fraction Monocytes Lymphocytes 
Purity (%) Yield (Ζ) Purity (%) Yield (Ζ) 
1 A.I ± 1.8 1.1 ± 0.5 98.9 ± 0.7 92 ± 4.3 
2 23.9 ± 13.8 6.2 ± 2.8 75.4 ± 13.7 6 ± 4.3 
3 92.4 ± 1.4 84.1 ± 4.1 6.5 ± 1.7 1.5 ±0.6 
4 80.8 ± 5.6 5.5 ± 3.1 17.8 ± 4.5 0.5 ± 0.3 
Table 1. Purity and y i e l d of lymphocytes and monocytes in the 4 e l u t r i a t e d 
f r a c t i o n s (mean % ± S.D.). Yield i s expres sed a s the r e l a t i v e d i s t r i b u t i o n of 
lymphocytes and monocytes over the 4 f r a c t i o n s ; p u r i t y as the composition 
within each f r a c t i o n . 
DISCUSSION 
Puri f ied monocytes are needed for study of t h e i r immunological and non-
immunological f u n c t i o n s . I s o l a t i o n on t h e b a s i s of f u n c t i o n a l p r o p e r t i e s 
means s e l e c t i o n and p o s s i b l e changes in c e l l u l a r metabolism induced by the 
i s o l a t i o n t e c h n i q u e '^. Counterflow c e n t r i f u g a t i o n avoids t h i s and prov ides 
an e x c e l l e n t method for c e l l s e p a r a t i o n . Sanderson e t a l . ? were the f i r s t t o 
r e p o r t c o n s i d e r a b l e p u r i f i c a t i o n of a small q u a n t i t y of monocytes by 
e l u t r i a t i o n . Weiner and Shah , L i o n e t t i e t a l . 1 0 , Contreras e t a l . 9
 a n < i 
Figdor e t a l '° d e s c r i b e d t h e i s o l a t i o n of la rge q u a n t i t i e s . A d i sadvantage 
of t h i s t e c h n i q u e , however, i s the r e l a t i v e l y blind s e p a r a t i o n in f r a c t i o n s 
o b t a i n e d a t f low-rates and r o t o r speeds based upon r e s u l t s of prev ious 
exper iments . The use of a r e c o g n i t i o n d e v i c e , c o n t i n u o u s l y measuring 
e l u t r i a t o r output, s o l v e s t h i s problem. F i r s t l y , one can a c t u a l l y see when a 
cohort of c e l l s i s c o l l e c t e d . In our experiments f r a c t i o n 1 i s c o l l e c t e d in 
456 ± 36 ml, f r a c t i o n 2 in 116 ± 56'ml and f r a c t i o n s 3 and 4 each in 50 ± 1 ml. 
Secondly, and even more important, the t e c h n i q u e al lows immediate r e c o g ­
n i t i o n of t h e e l u t e d c e l l t y p e . Contreras et a l . ' s t a t e d t h a t the e l u t r i a t i o n 
c h a r a c t e r i s t i c s of each donor ' s mononuclear c e l l s u s p e n s i o n are di f ferent, 
and each run has t o be t a i l o r e d i n d i v i d u a l l y for each donor. The r e l a t i v e l y 
wide range of rpm (2348-2444) found as the s e p a r a t i o n point in our s tudy 
confirms t h i s and c o r r o b o r a t e s the advantage of a s e p a r a t i o n method 
i n v o l v i n g d i r e c t v i s u a l i z a t i o n and r e c o g n i t i o n . On t h e o t h e r hand, Fogelman 
e t a l . ' and Figdor e t a l . documented highly r e p r o d u c i b l e monocyte 
i s o l a t i o n from run t o run without i n d i v i d u a l adjustment. Var iabi l i ty of flow, 
r o t o r s p e e d and temperature i n f l u e n c e s , i f not thoroughly s t a n d a r d i z e d for 
each run, the e l u t r i a t i o n c h a r a c t e r i s t i c s c o n s i d e r a b l y . In addi t ion, b io­
l o g i c a l spread in c e l l volume may account for t h e v a r i a t i o n in s e p a r a t i o n 
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point observed in the present study and may be of importance, when dealing 
with patients ' mononuclear cell suspensions. Using the isolat ion technique 
described, we achieved excellent purification of monocytes and lymphocytes 
with good recovery and viabil i ty. Moreover, the monocytes are gathered in a 
small effluent volume (50ml). The resul ts reported here with a relat ively 
small (50 ml) aliquot of peripheral venous blood as the source of the MNL 
suspensions and continuous identification of the eluted ce l l type, support 
the potential application of this purification technique in the study of 
monocyte function in patients. Preliminary resul ts on blood from patients 
with Hodgkin's disease, non-Hodgkin lymphomas, and infectious mono-
nucleosis are essent ia l ly similar to those reported here. 
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CHAPTER 4 
INCREASED ANTIBODY-DEPENDENT CYTOTOXICITY MEDIATED BY PURIFIED MONOCYTES 
IN HODGKIN'S DISEASE 
P.H.M. de Mulder, B.E. de Pauw, Α. Penninga, D.J.Th. Wagener and С. Haanen 
Publiahed in: Clinical Immunology and Immunopathology. 1983; 26:406-414 
SUMMARY 
Monocyte antibody-dependent cytotoxicity was studied in 19 patients with 
Hodgkin's disease and 14 normal controls. This function was investigated 
after isolation of the monocytes by means of a modified e lutnat ion 
technique. Direct sizing and counting of the cel ls , present in the effluent, 
enabled individual adjustment during each separation procedure. The 
absolute monocyte count in the peripheral blood of patients with Hodgkin's 
disease was higher (P < 0.002) than in normal controls. Nearly 90Í pure 
monocyte suspensions, representing 82$ of al l elutriated monocytes, were 
obtained. The e lu tna t ion characterist ics of the monocytes in both groups 
were essential ly the same, irrespective of marked interindividual dif-
ferences. Kill of antibody-coated chicken red blood cel ls was measured by 
DNA flow cytometry. In comparison to normal controls, a significantly 
increased (P < 0.0004), stage-independent, monocyte antibody-dependent 
cytotoxicity was found in patients with Hodgkin's disease. The percentage of 
k i l l in symptomatic patients tended to be higher than in the asymptomatic 
group; no correlation was found with the absolute number of circulating 
monocytes. 
INTRODUCTION 
In Hodgkin's d is tase (HD) a relative and/or absolute monocytosis, e s -
pecially in advanced stages, is not infrequently noted ' . Despite this 
observation, data concerning monocyte function in HD are scarce. Hitherto, 
most monocyte function studies have been performed on unfractionated 
с о 
mononuclear cells 0 ~ 0 or after purification using the adherent properties of 
monocytes ' . However, purified cell suspensions, obtained by techniques 
providing high recovery and minimal alteration of function, are required for 
optimal investigation of different cell types. Kohl et al., studying adherent 
mononuclear cel ls taken from five asymptomatic HD patients, found an 
impaired antibody-dependent cellular cytotoxicity (ADCC) against herpes 
simplex virus-infected target cells ' . On the contrary, Pehamberger et al. 
reported a significantly increased lysis of antibody-coated human red cel l s 
induced by unfractionated mononuclear cell suspensions . In this study 
antibody-dependent cel lular cytotoxicity (ADCC) was measured on monocytes 
obtained by a modified counterflow centnfugation (e lutnat ion) technique. 
In this procedure fraction cutting is based on continuous monitoring of the 
e l u t n a t o r output, hence optimizing purity and yield ''". 
Monocyte ADCC was analyzed in 19 patients with HD and 14 normal controls 
employing a recently developed in vitro ADCC system 1 1 measuring ki l l of 
antibody-coated chicken red blood cells by means of DNA flow cytometry, 
using the differences in DNA content of the two cel l populations involved. 
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PATIENTS AND METHODS 
Pat ien ta and c o n t r o l s . 
Per iphera l blood monooytea of 15 c o n s e c u t i v e l y diagnosed and un t rea ted 
p a t i e n t s with b iopsy-proven HD and 4 p a t i e n t s with r e l a p s e s were inc luded 
in t h i s s tudy. The h i s t o l o g i c mater ia l was c l a s s i f i e d according to the Rye 
1 ? 
conference modification of the Lukes-Butler classification . Staging 
procedures were carried out according to the cri teria recommended at the Ann 
Arbor conference '3, None of the patients had concomitant overt infectious 
disease. The c l in ical data are summarized in Table 1. A group of I1) healthy 
individuals of similar age and sex distribution served as controls; none of 
them was receiving any medication. 
Patients 
Female 
Male 
n-19 
6 
13 
Mean 
34 
29 
Age (years) 
Range 
16-60 
19-55 
Clinical stage 
Stage I IÏ Til 
A 3 3 2 
В - 1 2 
η 3 Ь 4 
Histology 
14 Nodular sclerosis 
2 Mixed cellulanty 
1 Lymphocytic predominance 
1 Lymphocytic depletion 
Table 1. Clinical data of the patient population 
Monocyte isolation. 
Monocyte suspensions were prepared as previously described (10). Briefly, 
approximately 50 ml venous blood obtained by venapuncture was hepannized, 
and subjected to Ficoll-Isopaque (1.077 g/ml) buoyant density centn-
IV η 
2 10 
6 9 
β 
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fugation (400 χ g; 30 min; 20oC), after threefold dilution with calcium- and 
magnesium-free Hank's buffered balanced salt solution containing 100 mg di-
K-EDTA/liter (HBBS). The isolated mononuclear cel l suspension was washed 
once and resuspended in 5-8 ml HBBS supplemented with 0.4$ bovine serum 
albumin (BSA). This sample was introduced into the e lutr iator (Beekman J2-21 
С centifuge equipped with a JE-6 elutriator rotor with a standard separation 
chamber). By gradually diminishing the centrifugal speed (rpm), cells were 
allowed to emerge from the separation chamber at a constant flow rate of 13.7 
ml/min. An optimal separation for each sample was established by means of 
scatter analysis of the effluent, enabling continuous monitoring of size and 
numbers. The first appearance of monocytes in the effluent was used as the 
separation point between lymphocytes and monocytes. In each run four 
fractions were collected: a lymphocyte, a mixed lymphocyte and monocyte, a 
monocyte and a ' res t ' fraction. Cytocentrifuged preparations of the 
elutriated fractions and peripheral blood smears were stained with May-
Grünwald-Giemsa and with nonspecific esterase . Differential counting was 
performed on 400 ce l l s . Viability was assessed with fluorescein dia-
cetate/Ethidium bromide and trypan blue exclusion as described previously 
1 0
. 
Antibody-dependent cel lular cytotoxicity assay (ADDC). 
ADDC was measured according to Attallah et al . . After ethidiuo bromide 
staining, chicken red blood cell (CRBC) targets can be distinguished readily 
from human effector cel ls with DNA flow cytometry, since the DNA content 
amounts to 2.5 and 6.0 pg per nucleus, respectively (Fig. 1). 
Effector cells . 
Isolated monocytes were resuspended in RPMI-Hepes-L-glutaraine at a 
concentration of 4 χ 10^/ml. 
Target cel ls . 
CRBC were prepared freshly for each assay using the same chicken donor. 
Approximately 0.5 ml heparimzed venous blood was washed five times in 
phosphate-buffered saline (PBS) and finally resuspended in RPMI-Hepes-L-
glutamine at a concentration of 4 χ 10° cells/ml. 
Antibody. 
A commercially available rabbit anti-CRBC IgG (R-anti CRBC, Unites States 
Biochemical Corp., Cleveland Ohio) served as antibody in a final dilution of 
1:40,000. 
Culturing. 
Cultures were carried out in t r ip l icate in 500μ1 round-bottom tubes (Luckham 
Ltd, Burgess Hill, Great Britain) with an effector to target (E/T) ratio of 2/1. 
The monocyte suspension (100 μΐ) and CRBC (50 μΐ) supplemented with either 
50 ul medium or 50 yl R-anti-CRBC were incubated for 90 mm at 370C. 
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СП ВС 
MONOCYTES 
VI HOUR INCUBATION 
PEAK 1 14091 CELLS 
PEAK 2 27902 CELLS 
MO/ CRBC 1 9 8 
• ^ . S -
MO 
CRBC 
Ig-COATEO 
PEAK 1 9232 CELLS 
PEAK 2 28519 CELLS 
MO/, CRBC 2 87 
-Τ ι %• 
DNA - CONTENT 
Fig. 1. Gould 5005 copy r e p r e s e n t i n g t h e histograms of the s u s p e n s i o n s with 
(bottom) and without (top) ant ibody. The r e l a t i v e DNA c o n t e n t i s i n d i c a t e d on 
t h e χ a x i s and c e l l number on the у a x i s . The surface of each peak r e p r e s e n t s 
t h e c e l l number. 
ADCC flow cytometry. 
The i n c u b a t i o n was s topped by adding 200 u l hypotonic ethidium bromide 
(EB: 0.1$ t r i sodium c i t r a t e and 25 mg/l i ter ethidium bromide; 30 mosmol/kg, 
pH 7.6) supplemented with 0.1$ Triton X- 100 (w/v) to each tube. After 
careful mixing and i n c u b a t i o n for at l e a s t 15 mm at ΐ) ο0, t h e s u s p e n s i o n s 
were d i l u t e d f u r t h e r with 800 μΐ hypotonic EB/Triton and analyzed by means 
of flow cytometry (ICP-11) (15). The DNA his tograms were recorded by a 
p a p e r - t a p e punch u n i t , read by a PDP 11/45 computer, and E/T r a t i o s 
c a l c u l a t e d . The f i n a l r e s u l t s were provided in hard-copy form by a Gould 
5005 u n i t (Fig. 1). 
Calculations. 
The percentage CRBC lysis due to monocyte cytotoxicity in the ADCC assay 
was calculated according to the formula: 
M0/CRBC - antibody 
ÍKill = 100 - χ 100. 
MO/CRBC + antibody 51 
S t a t i s t i c s . 
The Wilcoxon two-sample t e s t was used t o compare t h e r e s u l t s of ADCC 
between p a t i e n t s with HD and normal c o n t r o l s . 
RESULTS 
Relevant d a t a concerning t h e composition of t h e p e r i p h e r a l blood are 
p r e s e n t e d in Table 2. In 63$ of t h e p a t i e n t s l e u k o c y t o s i s ( leukocytes> 
10,000/mm3) was noted, mostly due to an i n c r e a s e d number of polymorphs. The 
r e l a t i v e proport ion of monocytes was normal, but t h e a b s o l u t e number of 
c i r c u l a t i n g monocytes (68$ of the p a t i e n t s had > 500 monocytes/mnP) was 
s i g n i f i c a n t l y i n c r e a s e d (P < 0.002). Likewise, t h e r e l a t i v e lymphocytopenia 
masked a normal mean number of c e l l s per cubic mil l imeter, a l though 7 out of 
12 p a t i e n t s with s t a g e I I I and IV had lymphocyte c o u n t s of l e s s than 
1500/mm3. Table 3 g i v e s t h e r e s u l t s of t h e monocyte i s o l a t i o n us ing 
counterflow c e n t n f u g a t i o n . Recover ies and p u r i t i e s a re s imi lar in the two 
groups; t h e contaminat ing c e l l s in t h e monocyte f r a c t i o n were mainly 
lymphocytes, some b a s o p h i l s , and very few segmented n e u t r o p h i l s . The 
s i m i l a r i t y of s e p a r a t i o n p o i n t s , in view of the q u i t e d i f fe rent composition 
of the p e r i p h e r a l blood, was s t r i k i n g . 
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Fig. 2. Monocyte ADCC of t h e p a t i e n t and c o n t r o l group 
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The l y t i c c a p a c i t y of t h e i s o l a t e d monocytes was a i g n i f i c a n t l y increased (P< 
0.0004) in HD compared to normal c o n t r o l s (30.2 ± 6.5% v e r s u s 19.1 ± 6.6%; 
Fig. 2). A s l i g h t , though not s i g n i f i c a n t , i n c r e a s e was noted with the 
presence of В symptoms (32.6 ± 6.1 % v e r s u s 28.1 ± 6.4%; Fig. 3). Stage of 
d i s e a s e was not r e l a t e d t o k i l l i n g c a p a c i t y (Fig. 4) and no c o r r e l a t i o n was 
found between t h e p e r c e n t a g e of k i l l and the number of c i r c u l a t i n g 
monocytes (r = 0.16). 
WBC/mm3 
Monocytes (%) 
Monocytes/mm3 
Lymphocytes (%) 
Lymphocytes/mm3 
Normal 
5300 ± 
5.4 ± 
287 ± 
36.7 ± 
1966 ± 
1300 
1.7 
110 
9.5 
724 
Hodgkin's disease Ρ 
13,400 ± 6400 
4.9 ± 2 
664 ± 366 
17.6 ± 16 
2052 ± 1982 
< 0.0002 
NS 
< 0.002 
< 0.0002 
NS 
400 ce l l s differentiated 
Table 2. Monocyte and lymphocyte numbers in the p e r i p h e r a l blood 
Normal Hodgkin's disease 
Purity of the monocyte 
fraction CO 89.2 ± 2.5 88.1 ± 4.7 
Relative yield of monocytes in 
the most enriched fraction (Z) 76.7 ± 10 82.5 ± 8 
Elutriation recovery (Z) 89 ± 11 84 ± 16 
Separation point (rpm) 2464 ± 161 2415 ± 141 
Yield of monocytes (x 106) 16 ± 5.6 26.8 ± 16 
Viability (Z) 98 98 
Table 3. R e s u l t s of monocyte i s o l a t i o n in t h e p a t i e n t and c o n t r o l group 
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DISCUSSION 
The ro le of the mononuclear phagocyte system in HD i s poorly understood. 
There are arguments for a monocyte-macrophage o r ig in of the pu ta t ive 
malignant c e l l in HD 1 ° . Bes ides lymphocytes, macrophages are important 
e f fec to r c e l l s in the ce l l -med ia ted immune r e s p o n s e , which i s impaired in HD 
' . To study the mononuclear phagocyte system in v i t r o , the pe r iphe ra l blood 
monocyte i s the bes t a c c e s s i b l e c e l l source . Avai lable data from the 
l i t e r a t u r e concerning monocyte function in HD are l imi ted and not con-
c l u s i v e . A poss ib l e exp lana t ion for the observed monocytosis in HD may be 
1 fì the increased medullary monocyte production as shown by Meuret et al. . 
Earlier studies on chemotactic response ' , ADCC against virus- infected 
target cells 9, adherence 1 " , and phagocytosis 2 0 indicated a diminished 
monocyte function in HD; other investigations, however, revealed a normal 1 ' 
or increased activity of the monocytes o>öi21i22>
 т
^
е
 discrepancy between 
these results may be partly attributed to differences in the effector cel l 
populations employed. Hitherto, study of monocyte function was partly 
hampered by the lack of an adequate, aselective method to obtain a 
sufficient number of monocytes without affecting the cel l function. 
Counterflow centnfugation seems to solve this problem. Our findings on 
peripheral blood, isolated mononuclear leukocytes (data not shown), and 
monocyte yield after e lu tnat ion corroborate the presence of an increased 
absolute number of monocytes in HD in comparison to normal controls. The 
e lutnat ion characterist ics of monocytes in both the patients and the 
control group did not differ essentially. However, the considerable 
interindividual differences in the separation points observed in both 
series, as indicated by the range in Table 3, underline the necessity of 
elutriation with direct recognition of the cel l s leaving the separation 
chamber. We obtained nearly 90? pure monocyte suspensions representing 
82% of al l monocytes subjected to e lutnat ion. The in vitro ADCC assay by 
means of DNA flow cytometry appeared to be an excellent method to assess the 
percentage of ki l l . Technical problems associated with labeling techniques 
are avoided and a substantial ki l l can be observed applying a low 
effector/target ratio, after a relatively short incubation period. Our 
resul t s show an increased ADCC in HD compared to normal controls. The 
increase is not stage related but more pronounced in patients with В 
symptoms. The lack of correlation (r = 0.16) between the number of 
circulating monocytes and the percentage ki l l argues against a major shift 
in functionally different monocytes in HD on the basis of monocytosis alone. 
The increased monocyte ADCC does not support the hypothesis of a 
macrophage effector defect as a cause for the diminished cellular immunity 
and susceptibility to infections. Furthermore this increased cytotoxicity in 
vitro seems unable to prevent effectively the spread of the Hodgkin lesions. 
Other studies on ADCC in non-lymphomatous malignancies 23> 2 Ч indicate that 
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Fig. 3. Monocyte ADCC in relation to absence (A) or presence (B) of В 
symptoms. 
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Fig. 1. Monocyte ADCC related to the s tage of d i s e a s e . 
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the increased lytic capacity of monocytes is not a HD-specific phenomenon. 
Katz " identified a diminished number of macrophages in uninvolved 
lymphoid tissue derived from patients with HD in comparison to normal 
controls. The increased production of leukocyte inhibitory factor in HD 26-
2° may in part explain the lack of expression of this enhanced monocyte ADCC 
at tissue and tumor level. 
56 
REFERENCES 
1. Wiseman BK. The blood pictures in the primary diseases of 
lymphatic system. JAMA 1963; 107: 2016-2022. 
2. Levinson B, Walter BA, Wintrobe MM, Cartwright GE. A clinical 
study in Hodgkin's disease. Arch Intern Med 1957; 99:519-535. 
3. Bobrove AM, Fuks Z, Strober S, Kaplan HS. Quantitation in 
Hodgkin's disease. Cancer 1975; 36:169-179. 
4. Schechter GP, Soehnlen F. Monocyte-mediated inhibition of 
lymphocyte blastogenesis in Hodgkin's disease. Blood 1978; 
52:261-271. 
5. Kaplan HS. Clinical evaluation. In: Hodgkin's disease, 2nd edn. 
Cambridge: Harvard University Press, 1980; 116-115. 
6. Steigbiegel RT, Lambert LH, Remington JS. Polymorph nuclear 
leukocyte, monocyte and macrophage bactericidal function in 
patients with Hodgkin's disease. J Lab Clin Med 1978; 88:54-62. 
7. Leb L, Merritt JA. Decreased monocyte function in patients with 
Hodgkin's disease. Cancer 1978; 41:1794-1803. 
8. Pehamberger H, Ludwig H, Pötzi Ρ, Knapp W. Increased monocyte-
mediated antibody-dependent cellular cytotoxicity (ADCC) in 
Hodgkin's disease. Br Cancer 1980; 41:778-781. 
9. Kohl S, Pickering LK, Sullivan MP, Walters DL. Impaired 
monocyte-macrophage cytotoxicity in patients with Hodgkin's 
disease. Clin Immunol Immunopathol 1980; 15:577-585. 
10. de Mulder PHM, Wessels JMC, Rosenbrand DA, Smeulders JBJM, 
Wagener DJTh, Haanen C. Monocyte purification with counterflow 
centrifugation monitored by contiuous flow cytometry. J Immunol 
Methods 1980; 47:31-38. 
11. Attallah AM, Folks T, Noguchi PD, Noguchi T. Detection of 
antibody-dependent cell-mediated cytotoxicity by automated flow 
cytometry. Comparison to a chromium release assay and 
characterization of the effector cell subpopulation. J Immunol 
Methods 1980; 36:325-333. 
12. Lukes RJ, Craver LF, Hall TC, Pappaport H, Rubin P. Report of 
the nomenclature committee. Cancer Res 1966; 26:1311. 
13. Carbone PP, Kaplan HS, Musshof К, Smithers DW, Tubiana M. 
Report of the committee on Hodgkin's disease staging 
classification. Cancer Res 1977; 31:1860-1861. 
14. Lawrence C, Grossman R. simple butyrate esterase stain for 
monocytes. Stain Technol 1980; 54:321-323. 
15. Wegmann F. In: Melamed R, Mullancy RF, Mendelsohn ML, Eds. Flow 
Cytometry and Sorting. New York: John Wiley & Sons, 1979; 673. 
16. Kaplan HS. pathology In: Hodgkin's disease, 2nd edn. Cambridge: 
Harvard University Press, 1980; 52-115. 
57 
17. Aiaenberg AC. Studies on delayed hypersensitivity in Hodgkin's 
disease. J Clin Invest 1962; 41:1964-1970. 
18. Meuret G, Schmitt E, Tseleni S, Widmer M. Monocyte production 
in Hodgkin's disease and non-Hodgkin's lymphoma. Blut 1979; 
37:193-200. 
19. Віаезе RM, Oppenheim JJ, Seeger HC, Waldmann Th. Lymphocyte-
macrophage interaction in antigen induced in vitro lymphocyte 
transformation in patients with Wiskott- Aldnch Syndrome and 
other diseases with anergy. Cell Immunol 1972; 4:228-242. 
20. Urbanitz D, Fechner I, Gross R. Reduced monocyte phagocytosis 
in patients with advanced Hodgkin's disease and lymphosarcoma. 
Klin Wochenschr 1975; 53:437-440. 
21. Goodwin JS, Messner RP, Bankhurst AD, Peake GT, Saiki JH, 
Williams RD. Prostaglandin-producing suppressor cells in 
Hodgkin's disease. N Engl J Med 1977; 297:963-968. 
22. Hillinger SM, Herzig GP. Impaired cell-mediated immunity in 
Hodgkin's disease mediated by suppressor lymphocytes and 
monocytes. J Clin Invest 1978; 61:1620-1627. 
23. Nyholm RE, Currie GA. Monocytes and macarophages in malignant 
melanoma II. Lysis of antibody-coated human erythrocytes as an 
assay of monocyte function. Br J Cancer 1978; 37:337-344. 
24. Hersch EM, Murphy SG, Gutherman JH, Morgan J, Quesada J, Zander 
A, Stewart D. Antibody-dependent cell-mediated cytotoxicity in 
human cancer: characterization of patient leukocyte activity 
and treatment effects. Cancer 1982; 49:251-260. 
25. Katz DR. The macrophage in Hodgkin's disease. J Pathol 1981; 
133:145-159. 
26. Ward PA, Berenberg JL. Defective regulation of inflammatory 
mediators in Hodgkin's disease. 
N Engl J Med 1974; 290:76-80. 
27. Golding B, Golding H, Lommitzer R, Jacobson R, Koornhof HJ, 
Rabson AR. Production of leukocyte inhibitory factor (LIF) in 
Hodgkin's disease. Clin Immunol Immunopathol 1977; 7:114-122. 
28. Petrin! H, Azzarà A, Polidori AR, Vatteroni ML, Caraccoilo F, 
Carulli G, Ambrogi F. Serum factors inhibiting some leukocytic 
functions in Hodgkin's disease. Clin Immunol Immunopathol 1982; 
23:124-132. 
58 
CHAPTER 5 
.MONOCYTE MEDIATED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN MALIGNANT 
LYMPHOMA AND SOLID TUMORS. 
Pieter H.M. de Mulder, MD, Ben E. de Pauw, MD, Erik С. van de Ven, Theo D.J. 
Wagener, MD, Clemens Haanen, MD. 
Accepted for publ ication in: Cancer. 
SUMMARY 
Monocyte-mediated a n t i b o d y - d e p e n d e n t c e l l u l a r c y t o t o x i c i t y (MO- ADCC) was 
s t u d i e d in 21 p a t i e n t s with Hodgkln'a d i s e a s e (HD), 15 p a t i e n t s with a l o n g -
l a s t i n g remiss ion of HD, 11 p a t i e n t s with non-Hodgkin lymphoma (NHL), 11 
p a t i e n t s with s o l i d tumors, and 15 normal c o n t r o l s . Lymphocyte ADCC (LY-
ADCC) was e v a l u a t e d in 12 p a t i e n t s with HD and 9 normal c o n t r o l s . Monocytes 
and lymphocytes were i s o l a t e d with c e l l - s c a t t e r monitored counterflow 
c e n t n f u g a t i o n providing high puri ty and y i e l d . ADCC was e v a l u a t e d by means 
of DNA flow cytometry, us ing a n t i b o d y - c o a t e d chicken red blood c e l l t a r g e t s 
(CRBC). In comparison with normal c o n t r o l s MO-ADCC was s i g n i f i c a n t l y 
i n c r e a s e d in HD (ρ < 0.0005), NHL (ρ < 0.005) and s o l i d tumors (ρ < 0.005). 
In p a t i e n t s in a l o n g - l a s t i n g complete remiss ion of HD MO-ADCC was in t h e 
normal range . LY-ADCC of 12 p a t i e n t s with HD was s i m i l a r to t h a t of 9 normal 
c o n t r o l s . In a l l experiments LY-ADCC was i n v a r i a b l y lower than MO-ADCC of 
t h e same donor, i n d i c a t i n g t h e monocyte as t h e most potent e f fector c e l l 
towards CRBC t a r g e t s . 
Our r e s u l t s i n d i c a t e : 1. Purif ied e e l s u s p e n s i o n s of both lymphocytes and 
monocytes are e s s e n t i a l to unrave l t h e i r r o l e as e f f e c t o r c e l l s . 2. LY-ADCC 
i n HD i s s imi lar to normal c o n t r o l s . 3. MO-ADCC enhancement i s not uncommon 
in mal ignant lymphoma and s e v e r a l so l id tumors. 4. Normal MO-ADCC in a group 
of s u c c e s f u l l y t r e a t e d p a t i e n t s with HD s u g g e s t s a d i s e a s e r e l a t e d 
i n d u c t i o n of enhanced MO-ADCC. 
INTRODUCTION 
Antibody-dependent c e l l u l a r c y t o t o x i c i t y (ADCC) i s a s e n s i t i v e immuno­
l o g i c a l defence mechanism p a r t i c i p a t i n g in t h e i n h i b i t i o n of n e o p l a s t i c 
growth · , in a l l o g r a f t r e j e c t i o n ^, and p a r a s i t e d e s t r u c t i o n . Different 
c e l l t y p e s , lymphocytes, monocytes and g r a n u l o c y t e s , a l l bearing membrane 
F c - r e c e p t o r s , are known t o p o s s e s s ADCC p r o p e r t i e s -'> . The s e n s i t i v i t y of 
an e f fec tor c e l l depends on both t a r g e t '» (e.g. tumor c e l l l i n e s , human red 
blood c e l l s , chicken red blood c e l l s ) and on t h e type of antibody 8>9i10p1 1, 
K- lymphocytes, for example, p r e f e r e n t i a l l y k i l l a n t i b o d y - c o a t e d tumor c e l l s 
and to a l e s s e r degree e r y t h r o c y t e t a r g e t s such as chicken red blood c e l l s 
(CRBC); whereas a t o t a l i n c a p a c i t y i s observed towards human ant i-B coated 
B - e r y t h r o c y t e s , which in turn are very s e n s i t i v e t a r g e t s for p e r i p h e r a l 
blood monocytes ' . Dealing with a mixed e f fec tor c e l l populat ion of varying 
composit ion, such as a mononuclear c e l l s u s p e n s i o n , mutual i n t e r a c t i o n and 
varying k i l l i n g c a p a c i t y of c e l l s and s u b s e t s should be taken into a c c o u n t . 
A p r e r e q u i s i t e for optimal e v a l u a t i o n of ADCC i s a well defined c e l l 
p o p u l a t i o n . 
I n t h e p r e s e n t study we e v a l u a t e d monocyte ADCC (MO-ADCC), using monocytes 
pur i f ied with c e l l - s c a t t e r monitored counterflow c e n t n f u g a t i o n (CFC), 
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minimizing s e l e c t i o n and funct iona l a l t e r a t i o n ^ . ADCC was e v a l u a t e d us ing 
a n t i b o d y - c o a t e d CRBC t a r g e t s by means of DNA flow cytometry, t h u s avoiding 
time consuming l a b e l i n g t e c h n i q u e s and e n a b l i n g measurement a f t e r a 
r e l a t i v e s h o r t i n c u b a t i o n period (90 min) ^ J S . i
n
 o r d e r t o compare 
lymphocyte and monocyte ADCC towards a n t i b o d y - c o a t e d CRBC, pur i f ied c e l l s , 
obtained in one i s o l a t i o n procedure, were used аз e f f e c t o r s . 
In a p r e v i o u s r e p o r t we showed an enhanced monocyte ADCC in Hodgkin's 
d i s e a s e (HD) in comparison to normal c o n t r o l s ^ . To i n v e s t i g a t e whether 
t h i s phenomenon i s r e s t r i c t e d t o p a t i e n t s with overt HD or i s l ikewise 
demonstrable in p a t i e n t s in c l i n i c a l remiss ion, we t e s t e d MO-ADCC in 15 
p a t i e n t s in a l o n g - l a s t i n g complete remiss ion. Eventual d i s e a s e s p e c i f i c i t y 
was s t u d i e d by measuring ADCC in a group of 11 p a t i e n t s with malignant non-
Hodgkin lymphomas and 11 p a t i e n t s with s o l i d tumors. 
MATERIALS AND METHODS 
P a t i e n t s and c o n t r o l s . 
The i n d i v i d u a l s s t u d i e d included 17 u n t r e a t e d p a t i e n t s with biopsy-proven 
HD, 4 HD in r e l a p s e , 15 HD in l o n g - l a s t i n g remiss ion, 11 prev ious ly u n t r e a t e d 
non-Hodgkin lymphomas (NHL), 11 with advanced so l id tumors and 15 heal thy 
i n d i v i d u a l s . The h i s t o l o g i c c l a s s i f i c a t i o n of t h e p a t i e n t s with HD was made 
according t o t h e Rye conference modif icat ion of t h e Lukes- Butler 
c l a s s i f i c a t i o n . Staging procedures were c a r r i e d out as recommended a t 
t h e Ann Arbor conference 1 ' . The histologic classification of NHL was based 
1 fl 
on the criteria proposed by Rappaport l o and clinical staging according to 
the criteria advised at the Ann Arbor conference 19. The clinical data are 
summarized in Tables 1-3. All persons, both patients and normal controls 
were without medication and overt infectious disease at the time of the 
study. 
Monocyte isolation. 
Monocyte suspensions were prepared as previously described by means of 
counterflow centrifugation (CFC) '^. Briefly: approximately 50 ml of 
hepannized peripheral blood was, after threefold dilution with either Hank's 
balanced salt solution or glucose phosphate buffer, subjected to Ficoll-
Isopaque (1.077 g/ml) buoyant density centrifugation (lOOxg; 30 min; 20oC. 
After washing, the mononuclear cell suspension was introduced into the 
counterflow centrifuge (Beekman J2-21C equipped with a JE-6 elutnator 
rotor with standard separation chamber). The tubing system and chamber were 
previously sterilized by thorough rinsing with 70 % ethanol. After loading 
the sample, cells emerge from the separation chamber mainly according to 
their size, by gradually diminishing the centrifugal speed at a constant 
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Hodgkin s d i s e a s e 
Age Stage 
*2 
10 
11 
12 
*I3 
14 
15 
16 
17 
*18 
19 
*20 
21 
19 
16 
38 
29 
21 
24 
21 
26 
40 
48 
19 
23 
26 
21 
33 
25 
37 
28 
55 
42 
60 
M 
F 
M 
M 
M 
M 
M 
F 
F 
M 
F 
M 
M 
F 
M 
M 
M 
M 
M 
F 
F 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
es 
es 
es 
es 
es 
es 
es 
es 
es 
es 
es 
IA 
IA 
IA 
IIA 
IIA 
IIA 
IIB 
UIA 
UIA 
UIA 
HIB 
HIB 
HIB 
IVA 
IVA 
IVB 
IVB 
IVB 
IVB 
IVB 
IVB 
LP 
NS 
LP 
NS 
MC 
NS 
NS 
NS 
NS 
LP 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
MC 
NS 
LD 
29 
22 
23 
39 
29 
29 
43 
33 
17 
38 
45 
36 
22 
34 
26 
30 
34 
34 
35 
26 
33 
Non-Hodgtun Lymphoma 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
43 
60 
58 
42 
53 
36 
64 
34 
49 
60 
58 
F 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
PS 
PS 
PS 
es 
es 
es 
es 
es 
es 
es 
es 
Ι E 
HA 
HE 
HIB 
IVA 
IVA 
IVA 
IVA 
IVB 
IVB 
IVB 
Dlff Hist. 
Foil.Lymph. 
Dlff.Hist. 
Centrobl. 
Dlff.Lymph. 
Dlff.Lymph. 
loll.Lymph. 
Foil.Lymph. 
Dlff.Hist. 
Dlff.Hist. 
True Hist. 
56 
33 
*Relapse of HD. PS-patho log ica l s tage; CS; c l i n i c a l s t a g e ; NS: nodular 
s c l e r o s i s ; LP: lymphocycic prédominance; MC: mixed c e l l u l a n t y ; LD: 
lymphocytic d e p l e t i o n ; PA* p a t h o l o g i c a l anatomy. 
1. Clinical data of the HD and the NHL group 
counterflow r a t e . Continuous c e l l - a o a t t e r monitoring of t h e e f f luent e n a b l e s 
d i r e c t r e c o g n i t i o n of both lymphocytes and monocytes and t h e r e f o r e 
determinat ion of t h e i r optimal s e p a r a t i o n point, independent of c e l l number 
and composit ion of t h e mononuclear c e l l s u s p e n s i o n . After e l u t r i a t i o n of t h e 
lymphocytes, compris ing 90 % of a l l lymphocytes with a pur i ty of 98$, a 
monocyte f r a c t i o n i s obta ined, c o n t a i n i n g about 80? of t h e e l u t r i a t e d 
monocytes with an average pur i ty of 90J in a 50 ml sample. Purity was 
e s t a b l i s h e d by d i f f e r e n t i a l count ing of 400 c e l l s in c y t o c e n t n f u g e 
p r e p a r a t i o n s , s t a i n e d with May- GrUnwald Giemsa and for n o n - s p e c i f i c 
e s t e r a s e . 
Antibody-dependent c e l l u l a r c y t o t o x i c i t y a s s a y (ADCC). 
MO-ADCC was measured as descr ibed p r e v i o u s l y Λ Freshly prepared c h i c k e n 
red blood c e l l s (CRBC) were used as t a r g e t s . Since the DNA c o n t e n t amounts 
to 2.5 pg and human e f fec tor c e l l s ( i . e . monocytes and lymphocytes) to б pg, 
t h e s e c e l l s can be d i s t i n g u i s h e d e a s i l y , a f t e r s t a i n i n g with hypotonic 
ethidium bromide (EB), by means of flow cytometry. The e f f e c t o r to t a r g e t 
r a t i o (E/T) was 2 : 1 . S e n s i t i z a t i o n of CRBC was c a r r i e d out with r a b b i t a n t i -
CHBC IgG (United S t a t e s Biochemical Corp. Cleveland/Ohio, USA) in a f i n a l 
d i l u t i o n of 1 : 40.000. I n c u b a t i o n s were c a r r i e d out in t r i p l i c a t e or 
q u a d r u p l i c a t e in a f i n a l volume of 200 μ 1 in 500 μ ΐ round-bottom t u b e s . 
I n c u b a t i o n mixtures c o n t a i n e d 100 Ml monocyte s u s p e n s i o n and 50 vl CRBC, 
both a t a c o n c e n t r a t i o n of 4 χ 106/ml, supplemented with e i t h e r 50 Pi r a b b i t 
anti-CRBC or medium (RPMI-Hepes-L- Glutamine) and i n c u b a t e d for 90 min a t 
37 0C. The a s s a y was s topped by adding 200 μΐ hypotonic ethidium bromide 
(30m 0smol/kg) supplemented with 0.1? Tri ton X-100 (v/v). After mixing and 
incubat ion for a n o t h e r 15 min a t 40C, DNA a n a l y s i s was performed with a flow 
cytometer (ICP-11, Phywé Göttingen Germany). The DNA his tograms were used to 
c a l c u l a t e M0/CRBC r a t i o . 
ADCC was computed according to the formula: 
M0/CRB - ant ibody 
% k i l l = 100 - ( ) χ 100 
MO/CRBC + ant ibody 
The same a s s a y was used t o determine ADCC of concomitant ly i s o l a t e d 
lymphocytes in a l imited group of p e r s o n s (n = 21) in order to compare ADCC 
c a p a c i t y of lymphocytes and monocytes. 
Most ADCC-assays of p a t i e n t s were combined with normal c o n t r o l s or with HD 
p a t i e n t s in long l a s t i n g complete r e m i s s i o n . 
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Years 
No Age Sex Stage PA Therapy duration CR ADCC % 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
11 
12 
13 
14 
15 
28 
49 
38 
25 
25 
54 
40 
69 
35 
43 
« 
29 
45 
51 
25 
F 
F 
F 
F 
F 
M 
M 
F 
F 
M 
F 
M 
M 
F 
F 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
PS 
es 
es 
es 
es 
es 
es 
es 
IIA 
IIA 
IIA 
IIA 
IIA 
IIA 
IIIA 
IIIA 
HIB 
HIB 
IVB 
IVB 
IVB 
IVB 
IVB 
NS 
US 
MC 
NS 
NS 
NS 
NS 
NS 
NS 
MC 
LD 
NS 
LD 
LD 
MC 
RT 
RT/CT 
RT 
RT 
RT 
RT 
RT/CT 
RT/CT 
CT/RT 
CT 
CT/RT 
CT/RT 
CT/RT 
CT/RT 
CT 
1 
22 
4 
8 
8 
2 
11 
4 
1 
4 
1 
1 
2 
0,7 
8 
20 
27 
7 
18 
14 
27 
28 
29 
15 
20 
29 
26 
26 
9 
7 
RT: radiotherapy; CT: chemotherapy; CR: complete remission, PA: 
pathological anatomy. 
Table 2. Clinical data of HD group in complete remission. 
No Age Sex Diagnosis Stage Localization ADCC% 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
58 
66 
79 
53 
50 
33 
53 
57 
65 
27 
46 
M 
M 
M 
M 
M 
M 
M 
F 
F 
M 
F 
Squamous cell 
Squamous cell 
Squamous cell 
Squamous cell 
Anapl. Ca 
Squamous cell 
Mesothelioma 
Undiff. Ca 
Hepatocell. Ca 
Ca 
Ca 
Ca 
Ca 
Ca 
Anapl. seminoma 
Adenocarcinoma 
T3N1M0 
T2N3MO 
T3N0M1 
T3N1MO 
ТЗ ОЧІ 
T4N3M0 
T4N0M0 
CS III 
-
CS HIB 
-
ENT 
ENT 
FNT 
ENT 
ENT 
ENT 
Abdomen 
Ovary 
Mediastinum 
Mediastinum 
Duodenum 
44 
45 
17 
26 
43 
41 
50 
26 
15 
36 
33 
Ca: carcinoma; Anapl : anaplastic ; ENT: ear, nose and throat; TNM : tumor, 
nodus, metastasis classification; CS: clinical stage, 
Table 3. Clinical data of the solid tumor group. 
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S t a t i s t i c s . 
The Wilooxon two-sample t e s t was used t o e v a l u a t e t h e s t a t i s t i c s i g ­
ni f icance of d i f f e r e n c e s . All r e s u l t s are given а з means ± s tandard 
d e v i a t i o n . P o s s i b l e i n f l u e n c e s of age and sex on t h e r e s u l t s were analyzed 
with anova ( a n a l y s e s of v a r i a n c e ) . Ρ < 0.01 was cons idered s i g n i f i c a n t . 
RESULTS 
I t can be seen from Tables 1-3 t h a t e x t e n s i v e d i s e a s e was p r e s e n t in most 
c a s e s . The sex and age d i s t r i b u t i o n of t h e groups s t u d i e d were not s imilar . 
As might be expected, the mean age of the HD p a t i e n t s was s i g n i f i c a n t l y lower 
than the NHL and t h e so l id tumor groups (30.9 ± 12.2 v e r s u s 50.6 ± 10.4 and 
53.^ ± I1·.? y e a r s ) . The e l u t n a t i o n recovery, pur i ty and y ie ld of the 
monocyte f r a c t i o n s were almost i d e n t i c a l for the groups s tudied (Table 4). 
The mean s e p a r a t i o n point between monocytes and lymphocytes was, d e s p i t e 
i n t e r m d i v i d u a l d i f f e r e n c e s , comparable for the v a r i o u s groups s t u d i e d . 
Lymphocyte pur i ty was s imi lar for both HD p a t i e n t s and c o n t r o l s (97.9 ± 2.6 
and 98.6 ± 0.3$ r e s p e c t i v e l y ) , r e p r e s e n t i n g 88.θ * 7.1 and 94.3 ± 2 .8Í of a l l 
e l u t r i a t e d lymphocytes . In order to e s t a b l i s h the major ef fector c e l l in the 
ADCC system, lymphocyte and monocyte mediated ADCC was determined in 12 
p a t i e n t s with a c t i v e HD and 9 heal thy c o n t r o l s . The mean lymphocyte-
mediated ADCC (LY-ADCC) of the HD p a t i e n t s was 6.8 ± 4.9 versus 7.0 ± 4.0$ 
for the normal c o n t r o l s . In each experiment monocyte-mediated ADCC (M0-
ADCC) was i nva r i ab ly h igher than LY-ADCC. The lowest M0-ADCC/LY-ADCC r a t i o 
found was 2 and the h ighes t 33. Cytocentnfuge p repa ra t ions of the incubated 
suspens ions con ta in ing monocytes, CRBC, and ant ibody, r evea led numerous 
engulfed CRBC in d i f fe ren t phases of degradat ion (Fig. 1). The cyto toxic 
a c t i v i t y of monocytes from p a t i e n t s with HD was s i g n i f i c a n t l y inc reased in 
comparison with normal con t ro l s and p a t i e n t s in s t a b l e complete remission 
(31.3 ± 7.1 v e r s u s 19.1 ± 6.1 and 20.1 ± 8.1$; Ρ < 0.0005 and Ρ < 0.001 
r e s p e c t i v e l y ) (Fig. 2). No di f ference was found between the group of heal thy 
v o l u n t e e r s and p a t i e n t s in complete remiss ion. Evaluat ion of the l y t i c 
c a p a c i t y of monocytes obtained from p a t i e n t s with advanced NHL and so l id 
tumors r e v e a l e d a s i g n i f i c a n t l y enhanced a c t i v i t y in comparison to normal 
c o n t r o l s (33.2 ± 12.5 and 34.2 ± 11.7 v e r s u s 19.1 ± 6.4$; both Ρ < 0.005). The 
r e s u l t s of MO-ADCC in HD, NHL and s o l i d tumors were not s i g n i f i c a n t l y 
d i f ferent . In view of the d i f ferences in age and sex d i s t r i b u t i o n of the 
popula t ions s t u d i e d , the r e s u l t s of MO-ADCC were a n a l y s e d regard ing t h o s e 
parameters . Nei ther c o r r e l a t i o n with age nor s i g n i f i c a n t d i f fe rences between 
male and female were observed. The e a r l i e r r e p o r t e d tendency towards 
augmented ADCC in HD p a t i e n t s with B-symptoms in comparison with a-
symptomatic p a t i e n t s was a l s o observed in the NHL group (43.0 ± 10, v e r s u s 
28.7 ± 11$) . 
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Fig. 1. Cytocentr i fuge p r e p a r a t i o n of monocytes with antibody coated 
chicken red blood c e l l s a f t e r 90 min i n c u b a t i o n a t 37 0 C. 
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Fig. 2. R e s u l t s of MO-ADCC in HD, HD in complete remiss ion (H0-R), погшаі 
c o n t r o l s , NHL, and s o l i d tumors (MAL) (Shaded a r e a = s tandard d e v i a t i o n ) . 
S t a t i s t i c a l a n a l y s i s : Wilcoxon two-sample t e s t . 
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Monocyte purity (%) 
Relative yield in the 
purest fraction 
Elutriation recovery 
N - 73 
HD 
89.4 ± 4.7 
82.5 ± 8 
84 ± 16 
21 
HD-REM 
89.8 ± 2.2 
79 ± 8 
87 ±11 
15 
NHL 
89.2 ± 3. 
78 ± 6 
88 ± 6 
11 
9 
Solid tumors 
88.4 ± 4.8 
72 ± 4 
85 ± 15 
11 
Normals 
89.5 ± 2.5 
76.6 ± 10 
89 ±11 
15 
HD-REM : Hodgkin's disease in complete clinical remission; NHL : non-Hodgkin lymphoma. 
Table 4. Elutriation characteristics of monocyte separation with CFC. 
DISCUSSION 
Antibody-dependent c e l l u l a r cy to tox i c i t y (ADCC) in malignant lymphoma and 
non-lymphomatoua mal ignanc ies was s tud ied us ing homogeneous lymphocyte 
and monocyte ef fec tor c e l l popu la t ions . These wel l -def ined c e l l f r ac t ions 
were obtained by counterflow cen t r i fuga t ion (CFC), which enab les c e l l 
s epa ra t i on , mainly based upon d i f fe rences in c e l l s i z e 1 ' » 2 0 . In combination 
with cont inuous c e l l - s c a t t e r monitoring of the e l u t r i a t o r output a very 
reproduc ib le i s o l a t i o n of monocytes and lymphocytes i s obta ined, both in 
pur i ty and y ie ld . Furthermore CFC prov ides , when compared with the most 
commonly used adherence t echn ique , func t iona l ly n o n - s e l e c t e d and un-
a l t e r e d monocytes. In the 73 s e p a r a t i o n s desc r ibed in t h i s study a mean 
monocyte puri ty of 89 % was achieved r e p r e s e n t i n g almost 78 % of a l l 
e l u t r i a t e d monocytes. For the lymphocyte p u r i f i c a t i o n in 21 experiments 
t h e s e f igures were 98$ and 91$ r e s p e c t i v e l y . ADCC in human cancer i s most 
often s tudied us ing mononuclear c e l l s a s e f f ec to r s 7,21,22,23,24,25,¿o^ 
Major effector c e l l s were defined on the b a s i s of c o r r e l a t i o n s observed 
between a subse t of c e l l s p resen t in t hose MNL suspens ions and the 
percentage of k i l l ' > 2 1 , 2 2 , 2 3
Ф
 Д F c - r e c e p t o r p o s i t i v e non-adherent small 
lymphocyte was i d e n t i f i e d as the main e f fec tor c e l l towards CRBC t a r g e t s , 
s tudying MNL-ADCC in human cancer ^ 1 . our r e s u l t s on ADCC with puri f ied 
monocyte and lymphocyte s u s p e n s i o n s do not support t h i s observa t ion . The 
monocyte appeared t o be t h e most potent e f fec tor c e l l in a l l 12 HD and 9 
normal c o n t r o l s which were s t u d i e d . Although we did not screen the 
lymphocyte s u s p e n s i o n s for F c - r e c e p t o r p o s i t i v i t y , i t i s known from the 
l i t e r a t u r e t h a t , in an almost i d e n t i c a l s e p a r a t i o n procedure, t h i s r e c e p t o r 
was p r e s e n t in 18$ of t h e puri f ied lymphocytes " . The d i screpancy may be 
exp la ined by the d i f ference in both c e l l s e p a r a t i o n technique and 
methodology of ADCC measurement. Cell d e s t r u c t i o n of s e n s i t i z e d erythroid 
t a r g e t s by monocytes i s probably due t o e x t r a c e l l u l a r c e l l l y s i s and 
p h a g o c y t o s i s 1 0 > 1 1 . This i s a l s o i n d i c a t e d by t h e cy tocentr i fuge p r e ­
p a r a t i o n a f ter i n c u b a t i o n . R a d i o l a b e l - r e l e a s e a s s a y s may underes t imate 
monocyte-mediated l y s i s , due to i n t r a c e l l u l a r r e t e n t i o n of the l a b e l a f t e r 
p h a g o c y t o s i s , which i s t h e r e f o r e not d e t e c t e d in t h e s u p e r n a t a n t . The 
r e s u l t s on LY-ADCC did not r e v e a l any d i f ference between HD p a t i e n t s and 
normal c o n t r o l s . This i s in agreement with e a r l i e r r e p o r t s . Using CRBC "
 an¿ 
Herpes v i r u s - i n f e c t e d Chang l i v e r c e l l t a r g e t s 2 9 with monocyte depleted 
lymphocyte suspens ions no increment was observed . 
In c o n t r a s t with t h i s observa t ion , MO-ADCC of p a t i e n t s with HD was 
s i g n i f i c a n t l y inc reased in comparison to a normal con t ro l group and a group 
of p a t i e n t s in a long l a s t i n g complete remiss ion . To our knowledge no 
prev ious study has demonstrated normal MO-ADCC af te r succes s fu l t reatment 
of HD p a t i e n t s . The s c a r c e data on MO-ADCC in HD in the l i t e r a t u r e are 
c o n f l i c t i n g . Two e a r l i e r p u b l i c a t i o n s on MO-ADCC, employing r e s p e c t i v e l y 
human red blood c e l l s (HRBC) 30
 an¿ he rpes v i r u s - i n f e c t e d Chang l i v e r 
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c e l l a ' аз t a r g e t s , r e p o r t e d a normal ^ and d e c r e a s e d ADCC ^ ' . In both 
s t u d i e s pur i f ied monocytes were used, obta ined by adherence ^9
 a r i çj albumin 
dens i ty g r ad i en t cen t r i fuga t ion 30. On the o the r hand, with use of MNL as 
ef fector c e l l s towards HRBC an augmented a c t i v i t y was found 2 ^ . 
In NHL a s i g n i f i c a n t l y i nc reased MO-ADCC was found in comparison to normal 
con t ro l s . MO-ADCC in p a t i e n t s with symptoms was higher in comparison to the 
asymptomatic group. For s t a t i s t i c a l a n a l y s i s the group was too small. This 
finding i s in c o n t r a s t with Holm et a l . " , who de tec ted no augmentation of 
MO-ADCC in 11 u n t r e a t e d p a t i e n t s with NHL. In order to i n v e s t i g a t e whether 
t h i s MO-ADCC increment was s p e c i f i c for lymphomatous mal ignancies , a 
cont ro l group of p a t i e n t s with so l id tumors was t e s t e d for MO-ADCC a c t i v i t y . 
Although remarkable v a r i a t i o n was found, the mean ADCC was s i g n i f i c a n t l y 
inc reased compared to normal con t ro l s , and no e s s e n t i a l d i f ference was seen 
in comparison to HD and NHL. Data concerning ADCC mediated by purif ied 
monocytes in non- lymphomatous mal ignancies are s c a r c e . Kragballe et a l 
found in v a r i o u s forms of acu te myeloid leukemia a dep re s sed an t ibody-
dependent k i l l i n g capac i ty 31. Reports on MNL-ADCC in so l id tumors ind ica te 
enhanced 2'>2^
ι
 normal ^ 1 » 2 4 , and a l s o diminished a c t i v i t y 2 ^ . In view of a 
r e c e n t study p o i n t i n g t o a r e l a t i o n between age and MNL-ADCC towards 
a n t i b o d y - c o a t e d HRBC 2 0 we analysed the i n f l u e n c e s of sex and age on MO-
ADCC for the e n t i r e group. No s i g n i f i c a n t inf luence was found, which i s in 
agreement with o t h e r s t u d i e s 2 0 t 2 1 * » 2 5 . T h e enhanced MO- ADCC in both 
malignant lymphomas and in a v a r i e t y of so l id tumors as p r e s e n t e d in t h i s 
study, s u g g e s t s t h a t t h i s i s a f e a t u r e not uncommon in malignant d i s e a s e . 
This enhancement of MO-ADCC might be due t o an i n c r e a s e d number of Fc-
r e c e p t o r s 32,33
 a
f t e r a c t i v a t i o n . Products of mixed l e u k o c y t e s c u l t u r e s are 
shown to s t i m u l a t e t h e e x p r e s s i o n of F c - r e c e p t o r s on human macrophages 33. 
Other s t u d i e s i n d i c a t e t h a t MO-ADCC and macrophage ADCC can be induced or 
augmented by lymphokines from ant igen and mitogen-s t imulated lymphocyte 
c u l t u r e s 34,35^ Furthermore f i b r o n e c t i n 3o
 a n i j lyaozyme 37 enhance 
monocyte-mediated t u m o r i c i d a l a c t i v i t y . Lysozyme was found t o be e levated 
in HD e s p e c i a l l y with the p r e s e n c e of c o n s t i t u t i o n a l (B) symptoms ^ . This 
p a r a l l e l s our o b s e r v a t i o n of more pronounced MO-ADCC in HD ' . In NHL, 
however, no e l e v a t e d lysozyme i s observed 39. Although the p r e c i s e 
a c t i v a t i o n mechanism i s unknown, i t i s tempting to assume t h a t a d i s e a s e 
r e l a t e d , immune or non-immune s t imulus i n i t i a t e s monocyte a c t i v i a t i o n in 
malignant lymphoma and in var ious s o l i d tumors. 
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SUMMARY 
To e v a l u a t e metabol ic f u n c t i o n a l i t y of monocytes and lymphocytes in 
Hodgkln'a d i s e a s e (HD) we s t u d i e d 3 enzymes of t h e intermediary metabolism, 
0-6-PDH, PHI, ICDH, and t h e acid h y d r o l a s e s , NAG and ACP. These enzymes were 
measured in puri f ied c e l l f r a c t i o n s of 9 p a t i e n t s with advanced d i s e a s e and 
11 normal c o n t r o l s . The c e l l s were i s o l a t e d with c e l l s c a t t e r monitored 
counterflow c e n t n f u g a t i o n . Enzymes were measured in t h e c e l l l y s a t e s by 
means of f luor imetr ie m i c r o a s s a y s . In t h e monocytes of HD p a t i e n t s a 
s i g n i f i c a n t l y i n c r e a s e d G-6-PDH a c t i v i t y was found (P < 0.01), i n d i c a t i n g 
an enhanced a c t i v i t y of t h e hexose monophosphate shunt (HMPS). The o t h e r 
enzymes showed no c l e a r d i f f e r e n c e s compared t o normal c o n t r o l s . The 
lymphocytes of HD p a t i e n t s showed a s i g n i f i c a n t l y augmented a c t i v i t y of 
both G-6-PDH (P < 0.001) and PHI (P < 0.01), po int ing to an i n c r e a s e d HMPS 
and g l y c o l y t i c a c t i v i t y . These f indings are in support of an enhanced 
metabol ic a c t i v i t y of both monocytes and lymphocytes in HD. 
INTRODUCTION 
Although t h e impairment of c e l l - m e d i a t e d immunity in Hodgkin's d i s e a s e (HD) 
i s well e s t a b l i s h e d · , data concerning lymphocyte and monocyte funct ion 
a r e not in mutual c o n c u r r e n c e . For both lymphocytes and monocytes, 
i n c r e a s e d ' ~ ' and diminished Ί » 2 ! 0 - 1 0 a c t i v i t i e s have been descr ibed . In a 
r e c e n t study we could c l e a r l y show an enhanced monocyte- mediated 
a n t i b o d y - d e p e n d e n t c y t o t o x i c i t y in HD p a t i e n t s , i n d i c a t i n g an i n c r e a s e d 
funct ion of t h e s e c e l l s . 
S ince i t may be assumed t h a t any f u n c t i o n a l change wi l l be a r e f l e c t i o n of 
a l t e r a t i o n s in the under ly ing metabolic p a t t e r n s , we measured the a c t i v i t y 
of f ive key enzymes in monocytes and lymphocytes of 9 p a t i e n t s with HD and 
11 normal c o n t r o l s . Monocytes and lymphocytes were i s o l a t e d with c e l l -
s c a t t e r monitored counterflow c e n t r i f u g a t i o n ( e l u t n a t i o n ) '^ and enzyme 
measurement made by means of microf luorimetric t e c h n i q u e s . The enzymes 
s t u d i e d were: g l u c o s e - 6 - p h o s p h a t e dehydrogenase (G-6-PDH) of the hexose 
monophosphate shunt (HMPS), t h e g l y c o l y t i c enzyme phosphohexose i somerase 
(PHI), t h e Krebs c y c l e enzyme i s o c i t r a t e dehydrogenase (ICDH) and two 
lysosomal enzymes N-ace ty l -ß -g lucosamidase (NAG) and acid phosphatase 
(ACP). 
MATERIALS AND METHODS 
Mate r ia l s 
Mate r i a l s used for the monocyte and lymphocyte i s o l a t i o n were descr ibed 
р г е т ю и з і у . G l u c o s e - 6 - p h o s p h a t e , nicot inamide adenine d i n u c l e o t i d e 
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phosphate (NADP) and NADPH, fl-uotose-ô-phosphate (grade I), G-6-PDH (type 
XV), l aoo i tnc acid (type I), L (+) lact ic acid (grade I), 4-methyl-
umbelliferone (4-MU) and linked derivatives (Ч-MU-P, 4-MU-NAG) were al l 
obtained from the Sigma Chemical Co, St. Louis, U.S.A. The fluorochrome 4',6-
diamidino-2-phenylindole. 2HCL (DAPI) was purchased from Boehringer Mann­
heim. Demineralized bovine serum albumin (BSA) (Povite, Amsterdam, The 
Netherlands). All other materials, as l is ted in Table 2, were of analytical 
purity and obtained from Merck (Darmstadt, Germany). 
Patients and controls 
Eight newly diagnosed biopsy-proven patients with Hodgkin's disease and 
one patient with a relapse after radiotherapy and chemotherapy were 
included in this study. The histological material was classified according 
to the Rye conference modification of the Lukes Butler classi f ication 3. 
Staging procedures were carried out according to the cr i ter ia recommended 
at the Ann Arbor conference . None of the patients had concomitant overt 
infectious disease. The cl inical data are summarized in Table 1. A group of 
11 healthy volunteers (10 men and 1 woman, age 30 ± 5 yr) served as controls. 
A 
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I I I 
1 
1 
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1 
4 
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n* 
3 
6 
Total - 9 patients age 37 ± 14 yr sex all male, histology 
4 nodular sclerosis. 4 mixed cellulanty and 1 lymphocytic predominance 
Table I. Patient population 
Monocyte and lymphocyte isolation 
The suspensions were prepared аз previously described ^ . Briefly, a 
mononuclear cel l suspension was obtained from 50 ml hepanmzed venous 
blood after Ficoll-Isopaque (1.077 g/ml) buoyant density centrifugation. 
After one wash step the sample was introduced into the elutr iator (Beekman 
J2-21 С centrifuge equipped with a JE-6 elutr iator rotor with standard 
separation chamber). By gradually diminishing the centrifugal speed at a 
constant counterflow rate, cells emerge from the separation chamber mainly 
according to their s ize. Continuous cell scatter monitoring enables optimal 
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separation for each sample. Four fractions were gathered, a lymphocyte 
fraction containing approximately 90Í of al l elutriated lymphocytes with a 
purity of 99%, a mixed lymphocyte and monocyte fraction, a monocyte fraction 
with about 80$ of the elutriated monocytes with an average purity of 90$ 
and, after flushing the tubing system, a rest fraction. After washing, the 
lymphocyte and monocyte fractions were further analyzed. Differential 
counting of May-Grilnwald-Giemsa and non- specific esterase '^ stained 
cytocentnfuge preparations was performed on 400 ce l l s . 
Biochemical assays 
The three enzymes of intermediary metabolism (G-6-PDH, PHI and ICDH) were 
measured by fluorimetrie determination of NADPH generated in the presence of 
appropriate substrates using either direct of coupled systems. The acid 
hydrolases (NAG and ACP) were assayed by fluorimetrie determination of 4-MU 
released from the corresponding 4-MU-linked derivatives. The individual 
assay methods are detailed in Table 2; in al l cases, preliminary experiments 
were carried out to verify the linearity of the system with respect to 
incubation time and enzyme activity. Cells (about 10 ) were lysed in 500 ul 
of aqueous bovine serum albumin solution (1 mg/ml; BSA) by one cycle of 
freeze-thawing followed by 2 χ 10 sec ultrasonication at 0oC. The lysate was 
centrifuged (5 min, 3000 χ g) and appropriate dilutions of the supernatant 
made in BSA. Duplicate 20 μ 1 aliquota of the diluted lysate were added to 
either 100 yl (G-6-PDH, PHI and ICDH) or 20 yl (NAG or ACP) of the pre- mixed 
reagent. After incubation at 370C, the reaction was stopped by cooling in ice 
and dilution and the fluorescence determined using a 'Fluonspec' fluori-
meter (Baird Europe B.V., The Hague, The Netherlands). After subtraction of 
appropriate blanks (BSA in place of lysate), activity was calculated as 
nmol/min.pg DNA by reference to NADPH or 4-MU standards. Preliminary 
experiments revealed that lysates showed no change in enzyme act ivi t ies for 
at least 3 months at - 80oC; al l samples were therefore assayed within this 
period after isolation of the cel ls . The DNA content of the lysate was 
determined by fluorescence of the complex with DAPI using a modification 
described by Mier et al. ' . 
S t a t i s t i c s 
The Wilcoxon two-sample tes t was used to compare the results , wich are given 
as means * standard deviation. 
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Reaction conditions 
Enzyme 
G-6-PDH 
PHI 
ICDH 
NAG 
ACP 
Composition Volume pH Time 
(ul) (min) 
Stopped by 
Tris, 5 umol 120 7.6 30 
MgCl2, 1 umol 
EDTA, 0.5 umol 
G-6-P, 20 nmol 
NADP, 10 nmol 
Tris, 5 umol 120 7.6 30 
MgCl2, 1 umol 
EDTA, 0.5 ymol 
F-6-P, 20 nmol 
NADP, 10 nmol 
G-6-PDH, 0.1 IU 
Tris, 5 umol 120 7.6 60 
MgCl2, 1 umol 
MnCl-, 1 umol 
EDTA, 0.5 umol 
Isocitrate, 20 nmol 
NADP, 10 nmol 
Lactate, U nmol 40 4.3 60 
4 MU-NAG, 20 nmol 
Lactate, 2 umol 40 3.6 60 
4 MU-P, 4 nmol 
0.2 M Na CO 
pH 10.5, 0.5 ml 
0.2 M Na 2C0 3 
pH 10.5. 0.5 ml 
H 20, 0.5 ml 
0.2 M Na2C0 
pH 10.5, 1 ml 
0.2 M Na2C0 
pH 10.5, 1 ml 
Fluorescence 
λ ex λ em 
t— 
342 455 
342 455 
342 455 
362 
362 
450 
450 
ex 
em 
extinction 
emission 
Table 2. Assay systems for the individual enzymes 
RESULTS 
After e lutr iat ion the mean purltiea of lymphocytes for the HD group and 
normal controls неге 97 * 3.7 and 99 * 0.6$ r e s p e c t i v e l y . For the monocyte 
suspens ions the corresponding purit ies were 87.0 * 5.8 and 88.2 * 3.3 %. The 
r e s u l t s of the enzyme measurements are presented in Figs 1 and 2. The G-6-
PDH a c t i v i t y of the monocytes from patients with HD (1.65 ± 0.29 nmol/mln yg 
DNA) was s ign i f icant ly increased (P < 0.01) in comparison to normal control 
monocytes (1.34 * 0.19). No differences were found in PHI, ICDH, NAG and ACP 
a c t i v i t y . In the lymphocytes of HD patients both G-6-PDH and PHI a c t i v i t y 
were s ign i f icant ly increased: G-6-PDH for HD was 0.67 ± 0.13, and for the 
normal controls was 0.45 * o.l (P < 0.001). PHI a c t i v i t y in HD and normals was 
r e s p e c t i v e l y 5.1 ± 1.1 and 3.9 ± 0.7 (P < 0.01). Although ICDH and the 
lysosomal enzymes NAG and ACP m HD lymphocytes tended to be higher, the 
di f ferences did not reach Ρ = 0.01. 
DISCUSSION 
The increased intrace l lu lar l e v e l of G-6-PDH in purified lymphocytes and 
monocytes of 9 pat ients with HD indicates an enhanced hexoae monophosphate 
shunt (HMPS) act iv i ty, re f lect ing ribose and NADPH production, e s s e n t i a l for 
DNA, RNA and protein s y n t h e s i s . In view of s tud ies pointing to an augmented 
HMPS act i v i ty in lymphokine-activated monocytes and in PHA- stimulated 
lymphocytes 1 ' , these f indings are in support of an increased lymphocyte 
and monocyte act i v i ty in HD. No correlation between age and G-6-PDH act iv i ty 
in monocytes, as described by King et al. , was observed in our study. 
Using radiolabeled g lucose, King et al. c reg is tered an increased HMPS 
a c t i v i t y in adherent monocytes from male pat ients with malignant lymphoma, 
and they a l so noted an augmented g l y c o l y t i c and Krebs cycle act iv i ty . 
However, the r e s u l t s m our study concerning the a c t i v i t y of PHI of the 
g l y c o l y t i c pathway and IDCH of the Krebs cyc le did not confirm t h i s 
observation for monocytes from patients with HD. In the lymphocytes, next to 
the increased HMPS act iv i ty, the observed l e v e l of PHI i s in agreement with 
op 
an increased function of the g l y c o l y t i c pathway, which i s supposed " to be 
involved in lymphoblastic tranaformation. The occurence of increased 
spontaneous lymphocyte transformation in pat ients with HD seems to 
corroborate the va l id i ty of t h i s observation. No a l terat ion in the Krebç 
cyc le enzyme ICDH was found in HD lymphocytes. There i s , to our knowledge, 
no information avai lable concerning NAG and ACP ac t iv i ty of monocytes of HD 
pat iente . These enzymes are important for the hydrolytic degradation of 
g lycoprote ins , mucopolysaccharides and g l y c o l i p l d s . The resu l t s of th i s 
study reveal a comparable l e v e l for monocytes of both HD patients and 
contro l · . The ac t iv i ty of several lymphocytic lysosomal enzymes are shown 
to be both increased 23,24
 a n ( j decreased in lymphoproliferative d i s e a s e s 
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Fig. 1. Act iv i ty of G-6-PDH, PHI, ICDH, ACP and NAG in monocytes from p a t i e n t e 
with HD and normal c o n t r o l s . 
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Fig. 2. Activi ty of G-6-PDH, PHI, ICDH, ACP and NAG in lyepfcoeytee free 
p a t i e n t s with HD and normal c o n t r o l s . 
19 
. Woesaner ¿ D , studying the lysosomal enzyme β- glucuronidase In 
lymphocytes from patients with HD, found values within or above the normal 
level. Our figures for NAG and ACP activity tended to be increased in HD 
lymphocytes without reaching a s ta t i s t ica l ly significant level (P = 0.01). 
In conclusion, our findings are in support of an increased function of 
monocytes and lymphocytes in HD. 
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CHAPTER 7 
CHARACTERIZATION OF MONOCYTE MATURATION IN ADHERENT AND NON-ADHERENT 
CULTURES AND ITS APPLICATION TO STUDY MONOCYTE DIFFERENTIATION IN 
HODGKIN'S DISEASE 
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SUMMARY 
Monocytes pur i f ied with c e l l s c a t t e r monitored counterflow c e n t n f u g a t i o n 
were cu l tu red in p l a s t i c (adheren t ) and in t e f lon cu l tu re bags (non-
adheren t ) . Maturation was monitored during 15 days by measuring i n t r a -
c e l l u l a r a c t i v i t y of 3 enzymes of intermediary metabolism: g l u c 0 3 e - 6 -
phosphate dehydrogenase (G-6-PDH), phosphohexose isoraerase (PHI) and 
i s o c i t r a t e dehydrogenase (ICDH), and the two ac id h y d r o l a s e s : ac id 
phosha tase (ACP) and N - a c e t y l - ß - g l u c o s a m i m d a s e (NAG). In the adheren t 
macrophages G-6-PDH showed an increment of 26 t imes the 2 h value , for PHI 
and ICDH was t h i s 3 and 5 t imes r e s p e c t i v e l y . For NAG and ACP a 20 and 47 fold 
i nc r ea se was found. In t e f lon grown macrophages a s i g n i f i c a n t l y lower G-6-
PDH a c t i v i t y was seen a f t e r 15 days in comparison to p l a s t i c adherent 
macrophages (p < 0.0002), i n d i c a t i n g a c t i v a t i o n by adherence . For the o the r 
enzymes s imilar va lues for both cu l tu re moda l i t i e s were found. The 
s i gn i f i c a n t l y , cycloheximide i n s e n s i t i v e , h igher v a l u e s for G-6-PDH, PHI and 
ICDH in 2 h adherent monocytes in comparison with non-adheren t monocytes, 
sugges t a r e l a t i o n s h i p between adherent c apac i t y and the l e v e l of 
intermediary metabolism. The ove ra l l y ie ld of adheren t macrophages was 35 % 
in con t r a s t with 89% for the in suspens ion cu l tu red macrophages. This 
co r robora tes the e x i s t e n c e of adherent and non-adhe ren t monocytes, both 
capable of maturation to macrophages. In 14 p a t i e n t s with advanced 
Hodgkin's d i s e a s e (HD) and 14 normal con t ro l s monocyte maturation was 
s tud ied applying both c u l t u r e moda l i t i e s . The enzyme l e v e l s , r e f l e c t i n g 
growth and intermediary metabolism, were s imi la r for both groups, in non-
adherent as well as in adherent grown macrophages. The adherent c apac i t y 
and y ie ld , both in p l a s t i c and in tef lon, a f t e r 15 days was comparable for 
both groups . I t was concluded t ha t monocyte maturat ion in the presence of 
au to logous serum was q u a l i t a t i v e l y and q u a n t i t a t i v e l y normal in advanced 
HD; t h i s i s in favour of an i n t r i n s i c a l l y normal funct ion of monocytes in HD. 
INTRODUCTION 
The blood monocyte i s der ived from the granulocyte /macrophage progeni tor 
c e l l in the bone marrow. This c e l l type i s a t r a n s i t form in the development 
t o the va r ious types of t i s s u e macrophages, t o g e t h e r forming the mono-
n u c l e a r phagocyte system (MPS) 1 . The c e l l s of t h i s system exhib i t d i s t i n c t 
morphologica l f e a t u r e s , and d i f fe ren t func t iona l and metabol ic c h a r a c t e r i s -
t i c s a t va r ious l e v e l s of d i f f e r en t i a t i on and maturat ion 2 i3i4,5,b,7> Severa l 
i n v e s t i g a t o r s have shown t h a t during in v i t ro c u l t u r i n g of monocytes, 
c e l l u l a r pe rox idase a c t i v i t y d e c r e a s e s >^ S ' - n u c l e o t i d a s e a c t i v i t y as well 
i n c r e a s e s ' as d e c r e a s e s to low l e v e l s a f t e r 7 days , and tha t the 
lysosomal enzymes acid phospha tase (ACP) ^> and N-ace ty l -B-g lucosami -
m d a s e (NAG) 4 · ' i n c r e a s e . 
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We studied intracellular key enzyme activities as parameter of monocyte 
maturation. Monocytes were isolated with cell scatter monitored counterflow 
centrifugation ö>' and cultured in plastic tubes for 15 days, enabling the 
study of both adherent capacity and the maturation pattern of the adherent 
cells. Culturing in hydrophobic teflon bags '"' permitted the determination 
of monocyte maturation in suspension. Cultures were monitored by measure-
ment of the intracellular levels of two lysosomal enzymes: ACP and NAG as 
markers for cell growth, and three enzymes of the intermediary carbohydrate 
metabolism: glucose-6-phosphate dehydrogenase (G-6-PDH), phosphohexoae 
isomerase (PHI) and isocitrate dehydrogenase (ICDH). G-6-PDH is the first 
enzyme in the hexose monophosphate shunt (HMPS), generating NADPH the major 
source of reducing power in the cell and ribose-5-phosphate a component of 
important biomolecules such as RNA, DNA and ATP. Glucose utilization through 
11 IP 
this pathway is shown to increase during activation of macrophages > . 
PHI and ICDH are enzymes of the glycolytic pathway and the Krebs' cycle 
respectively, and reflects energy supply as ATP formation. 
Recent publications indicate a correlation between a diminished in vitro 
maturation and a poor prognosis in patients with solid tumours 13i14 . in 
Hodgkin's disease (HD) no information is available concerning quantitative 
and qualitative monocyte maturation in vitro. There is conflicting indirect 
in vivo evidence pointing towards either a diminished 15,ib
 o r n o r m a i 
monocyte maturat ion ' . In 14 p a t i e n t s with advanced HD and 14 normal 
con t ro l s t h i s d i f f e r e n t i a t i o n proces was eva lua ted in v i t ro us ing both 
cu l tu re moda l i t i e s . 
MATERIALS AND METHODS 
Pa t ien t s and c o n t r o l s . 
The p a t i e n t group s tud ied cons i s t ed of 13 p a t i e n t s with newly diagnosed HD 
and 1 p a t i e n t in r e l a p s e ; 4 women and 10 men, ranging in age from 16 to 68 
yea r s (mean age , 30 y e a r s ) . Table 1 summarizes c l i n i c a l s t age , d i s e a s e 
a c t i v i t y and h i s t o l o g y . Staging procedures were carr ied out according to the 
c r i t e r i a recommended a t the Ann Arbor conference . The h i s t o l o g i c a l 
mater ia l was c l a s s i f i e d according to the Rye conference modification of the 
Lukes-But le r c l a s s i f i c a t i o n 1 ^ . A group of 14 heal thy vo lun tee rs served as 
normal c o n t r o l s . None of the p a t i e n t s and normal con t ro l s were t ak ing any 
medication or had over t i n f ec t i ous d i s e a s e . 
Monocyte i s o l a t i o n . 
Monocytes were i s o l a t e d as descr ibed p rev ious ly with the use of c e l l s c a t t e r 
monitored counterflow cen t r i fuga t ion °t"t20. An average pur i ty of 89 if, 
r e p r e s e n t i n g almost 80$ of a l l e l u t r i a t e d monocytes was achieved for both 
p a t i e n t s and normal c o n t r o l s . 
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PS l i A 
PS 11 В 
(Ь I I I в 
CS η А 
CS IV в 
2 
1 
5 
1 
5 
(NS,MC) 
(MC) 
(4NS,1MC) 
(NS) 
(1 LD , 4 N S ) 
NS Nodular Sclerosis, MC Mixed Cellularity, 
LD LymphocyLic depletion , PS Pathological 
Stage, CS Clinical Stage 
Table 1. Cl in ica l data of 1^1 p a t i e n t s with HD 
Adherent monocyte c u l t u n n g . 
F r e s h l y i s o l a t e d monocytes were resuspended a t a c o n c e n t r a t i o n of 2 χ 
lO^/ml in l ight protec ted, RPMI-hepes-L-glutamine (Gibco, c a t . no. 1(30-1800, 
Grand I s land Biologic Company, New York, U.S.A.) and 10$ auto logous serum. 
One ml of t h i s suspension was seeded in p l a s t i c f la t bottomed tubes (Costar, 
no 3393, 16 χ 93 mm, Cambridge, Mass. U.S.A.) and c u l t u r e d a t 370C for 
d i f ferent time i n t e r v a l s (2 h, 1,3,5,7,10 and 15 d a y s ) . No a n t i b i o t i c s were 
added nor was the tube opened or the medium r e f r e s h e d during the c u l t u r e 
per iod. Cultures were performed in duplo. C u l t u n n g was stopped by d e c a n t i n g 
t h e supernatant and n o n - a d h e r e n t c e l l s . Loosly a d h e r e n t c e l l s were removed 
by r i n s i n g (5 times) with 1 ml phosphate buffered s a l i n e (PBS) 0,5$ v/v human 
serum albumin (Albumine Merieux 20$, Rhône-Poulenc, C h a r b o n n i e r e s - l e s -
Bains, France) , and the adherent c e l l s were lysed with water/BSA so lu t ion (1 
mg bovine serum albumin/ml water) to r e l e a s e t h e i r i n t r a c e l l u l a r enzyme 
con ten t . After thorough mixing of the l y s a t e the samples were s tored a t -
80oC, for measurement of enzyme a c t i v i t y and DNA con ten t . 
Monocyte c u l t u n n g in suspens ion (non-adheren t ) . 
Culturing was performed m hydrophobic te f lon bags (TCB) (Dupont de Nemours 
and Co., Switzerland; gauge 25 mm, according to van der Meer et a l . . 
Fresh ly i so l a t ed monocytes were resuspended in b ica rbona te buffered RPMI-
1640 (Flow Laborator ies , I r v ine , Scot land) con ta in ing 1 $ glutamine (Micro 
Bio log ica l Associa tes , Bethesda, Maryland, U.S.A.) a t a concen t ra t ion of 3 x 
10-Vml in the presence of 10$ auto logous serum. Five ml of t h i s c e l l 
suspens ion was in jec ted gen t ly in to the TCB, and a f t e r d ia thermica l ly 
s e a l i n g of the opening, cu l tu red with 10$ CO2 in a i r in a humidified 
atmosphere at 370C. Culturing was stopped a f t e r 15 days by a s p i r a t i o n of the 
c e l l suspens ion af ter gen t l e kneading of the TCB. After one wash s t ep the 
c e l l s were resuspended in PBS. Samples were t aken for count ing, c y t o -
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c e n t r i f u g e p r e p a r a t i o n s and enzyme s t u d i e s . Cytocentr i fuge p r e p a r a t i o n s 
were s t a i n e d for May-Grunwald-Giemsa and for non — s p e c i f i c e s t e r a s e . 
Enzyme measurements were done on 2 χ 10-> c e l l s , a f t e r p e l l e t i n g , l y s i s in 0.5 
ml H2O/BSA s o l u t i o n and s t o r a g e at - 80 o C. 
Est imation of macrophage y ie ld . 
Cel l recovery In t h e p l a s t i c c u l t u r e s was e v a l u a t e d a f t e r 2 hours and 15 
days by measurement of t h e DNA c o n t e n t in 1 ml lysed uncul tured c e l l 
s u s p e n s i o n and In t h e l y s a t e of the a d h e r e n t c e l l s a f te r 2 hours and 15 days 
c u l t u n n g . Recovery was expressed as p e r c e n t a g e and c a l c u l a t e d from t h e 
r a t i o : 
DNA g/ml at 2 h 
— ^ ^ ^ ^ ^ - ^ — ^ ^ ^ — (2h recovery) 
DNA g/ml a t t = 0 
and 
DNA g/ml a t 15 days 
(15 days recovery) 
DNA g/ral a t 2h 
Macrophage y ie ld from t h e tef lon c u l t u r e s was c a l c u l a t e d from: 
c e l l s χ 10 6 in TCB at 15 days 
c e l l s χ 10° i n i t i a l l y i n j e c t e d . 
Cel l count ings were performed with a c o u l t e r counter model ZF. Viabil ity was 
t e s t e d by means of t rypan blue e x c l u s i o n . 
Biochemical a s s a y s . 
Enzyme measurements were performed with a f luor imetr ie micro a s s a y as 
descr ibed prev ious ly . The t h r e e i n t r a c e l l u l a r enzymes of intermediary 
metabolism, G-6-PDH, PHI and ICDH were measured by f luor imetr ie d e t e r ­
mination of NADPH g e n e r a t e d from NADP in the p r e s e n c e of a p p r o p r i a t e 
s u b s t r a t e s us ing e i t h e r d i r e c t or coupled systems. The acid h y d r o l a s e s , NAG 
and ACP, were a s s a y e d by f luorimetr ie determinat ion of 4- methylumbel-
l i f e r o n e r e l e a s e d from l inked d e r i v a t i v e s . After thawing of the samples, they 
were sub jected to 2 χ 10 s e c . u l t r a s o m c a t i o n a t 0oC and af ter c e n t n f u g a t i o n 
twenty v l of t h e l y s a t e was incubated in duplo with the a p p r o p r i a t e 
s u b s t r a t e s and f l u o r e s c e n s e determined. Act iv i ty was expressed in nmol/min. 
ug DNA. 
The DNA c o n t e n t of t h e l y s a t e was measured by f l u o r e s c e n s e of t h e complex 
with t h e fluorochrome V S - d i a m i d i n o ^ - p h e n y l i n d ó l e - 2-HCL. 
Θ7 
S t a t i s t i c s . 
The Wilooxon two sample t e s t was used to e v a l u a t e t h e r e s u l t s . Numbers are 
given as mean ± s tandard d e v i a t i o n . 
RESULTS 
Enzyme changes during c u l t u n n g of p l a s t i c - a d h e r e n t monocytes. 
Monocyte maturation and metabolic a c t i v i t y were q u a n t i f i e d by t h e d e t e r ­
mination of enzyme a c t i v i t i e s at di f ferent time i n t e r v a l s . The r e l a t i v e and 
a b s o l u t e changes of i n t r a c e l l u l a r enzyme a c t i v i t i e s of p l a s t i c a d h e r e n t 
monocytes are depicted in Fig 1. In a l l experiments (n = 6) a s imi lar p a t t e r n 
was to be seen. G-6-PDH showed an increment of 26 times the l e v e l observed 
a f t e r two hours a d h e r e n c e , for PHI and ICDH t h i s was 3 and 5 t imes 
r e s p e c t i v e l y . The acid h y d r o l a s e s ACP and NAG r e v e a l e d an i n c r e a s e of 47 
and 20 times t h e i r b a s i c l e v e l . After 7 days t h e curve of a l l enzymes 
f l a t t e n e d , but a s t i l l f u r t h e r i n c r e a s e was observed with prolonged 
c u l t u n n g . This change in enzyme a c t i v i t y p a r a l e l l e d t h e l i g h t microscopica l 
(phase c o n t r a s t ) changes in most c e l l s such a s i n c r e a s e in s i z e , and t h e 
appearance of cytoplasmic g ranulae . 
Enzyme a c t i v i t y in n o n - a d h e r e n t ( tef lon) c u l t u r e d monocytes. 
After 15 days no s i g n i f i c a n t d i f ferences were found in PHI, ICDH, NAG and ACP 
a c t i v i t y between p l a s t i c and TCB-cultured macrophages . However, a s i g ­
n i f i c a n t l y higher G-6-PDH a c t i v i t y was observed m t h e p l a s t i c - a d h e r e n t 
macrophages in comparison with the non-adherent te f lon grown macrophages 
(53.7 ± 15.5 ver sus 31.9 ± 13.6 nmol/min. ug DNA; ρ < 0.0002). May-Grunwald-
Giemsa and n o n - s p e c i f i c e s t e r a s e s t a i n e d c y t o c e n t n f u g e p r e p a r a t i o n s 
c o n s i s t e d of 95% or more macrophages (Fig. 2). The Number of b i-or 
mul t inucleated c e l l s was 1 % or l e s s . 
Inf luence of adherence on enzyme a c t i v i t y 
The intermediary metabolism r e p r e s e n t i n g enzymes, G-6-PDH, PHI and ICDH, of 
2 h adherent monocytes, were markedly e l e v a t e d in comparison with f reshly 
i s o l a t e d monocytes (Table 2). No such d i f f e r e n c e s were found for NAG and 
ACP. This i n c r e a s e d a c t i v i t y of intermediary metabolism might be due t o 
e i t h e r a c t i v a t i o n , s e l e c t i o n or both. Act ivat ion would imply denovo 
s y n t h e s i s of t h e s e enzymes, because r e l e a s e or a c t i v a t i o n of i n a c t i v e forms 
i s never demonstrated. To abo l i sh p r o t e i n s y n t h e s i s , cycloheximide (2 
ug/ml) was added to t h e c e l l s u s p e n s i o n s in 5 exper iments . The r e s u l t s are 
shown in Table 3. For a l l enzymes both lysosomal and of the intermediary 
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Fig. 2. May-Grünwald-Giemsa stained cytocentrifuge preparation of teflon 
grown macrophages (x 400). 89 
metabolism, no d i f f e r e n c e s in a c t i v i t y were found between t h e adherent c e l l s 
c u l t u r e d in the p r e s e n c e of cycloheximide and t h o s e without. Evaluat ion of 
enzyme a c t i v i t y in t h e non- adherent c e l l s r e v e a l e d very low non-
over lapping v a l u e s for G- 6-PDH, PHI and ICDH in comparison with t h e 
a d h e r e n t c e l l p o p u l a t i o n (Table 4). No such d i f f e r e n c e s were observed for 
t h e ac id h y d r o l a s e s NAG and ACP. 
Macrophage y ie ld in a d h e r e n t p l a s t i c (n = 28) and n o n - a d h e r e n t (tef lon; η = 
22) c u l t u r e s . 
The number of a d h e r e n t monocytes a f ter 2 h was 50 ± '\2% of t h o s e o r i g i n a l l y 
s e e d e d . The y ie ld of macrophages af ter 15 days was 70 ± 20 Í of the number 
adherent a f t e r 2 h. Macrophage y ie ld from the TCB a f t e r 15 days was 89 ± 
1 3 Í . Viabi l i ty was 93 ± 2%. 
Monocyte maturat ion in p a t i e n t s with HD and normal c o n t r o l s . 
In 14 p a t i e n t s with HD and 14 normal con t ro l s monocyte adherence and 
subsequen t changes in enzyme content over a 15 day cu l tu re period were 
measured. In 11 p a t i e n t s and 11 normal c o n t r o l s a l s o te f lon grown 
macrophages were s tud i ed . The majority of the p a t i e n t s was suffer ing from 
advanced a c t i v e d i s e a s e (71 Í III/IV B; Table 1). The adherent capac i ty of 
monocytes a f t e r 2 h was for both groups comparable (48 ±12, normal con t ro l s 
v e r s u s 51 ± 11 % for the HD group) After 15 days a s imi lar adheren t 
macrophage y i e ld was found (73 ± 27Í and 74 ± 23% r e s p e c t i v e l y ) . The 
pa t t e rn of enzyme changes in the adherent monocytes as shown in Fig 1. was 
for both groups i d e n t i c a l . No s ign i f i can t d i f f e rences in enzyme a c t i v i t i e s 
were found (P < 0.01 )( Table 5), although G-6-PDH and ICDH values in the HD 
group tended to be s l i g h t l y h igher (Fig 3). This tendency was not observed in 
the suspens ion grown macrophages. The 3 enzymes of intermediary metabolism 
and the 2 acid hydro la ses in the teflon grown macrophages were s imi lar for 
both groups . Macrophage y ie ld in the suspens ion c u l t u r e s was for both HD 
p a t i e n t s and normal c o n t r o l s i d e n t i c a l (89 ± 13$ and 89 ± 14$ r e s p e c t i v e l y ) . 
G-6-PDH a c t i v i t y of f resh ly i s o l a t e d monocytes from 20 p a t i e n t s with HD 
( t h i s inc luded 9 p a t i e n t s of chapte r 4) r evea led a s i g n i f i c a n t l y h igher 
a c t i v i t y in comparison with t hose from 24 normal c o n t r o l s (1.67 ± 0.44 and 
1.26 ± 0.31 nmol/min. ug DNA r e s p e c t i v e l y , Ρ < 0.0006). No such di f ference, 
however was observed in t h e adherent popula t ion a f t e r 2 hours (2.42 ± 1.2 
and 1.90 ± 0.78 nmol/min. ug DNA r e s p e c t i v e l y , Ρ = 0.19). 
DISCUSSION 
The exact r o l e of the c i r c u l a t i n g monocyte i s not yet e l u c i d a t e d and i s s t i l l 
an ob ject of i n v e s t i g a t i o n . I t i s not c l e a r whether t h e monocyte has a major 
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t . 0* 
t - 2h 
1.39 ± 0.51 
2.38 t 1.03 
14.4 ± 3 . 7 « 
21.3 t 8.8 
0,47 1 0,15*** 
1.68 1 0.81 
0.48 t 0.13 
0.55 ± 0.22 
0.12 t 0.02 
0.11 1 0.02 
31 
31 
* values of earlier experimente as described in chapter 6 are included η - 20 
** Ρ < 0.001 
*** Ρ < 0.0005 
Activity : ronol/min.yg DNA 
Table 2. Enzyme activity of freshly isolated monocytes and after 2 h 
adherence. 
G-6-PDH PHI ICDH HAG ACP η 
cyc lohex imide - 2 . 9 1 ± 1 . 3 6 n S 2 4 . 9 ± 8 . b ™ 0.75 ± 0.30™ 0 . 7 5 t 0 . 2 0 η β 0 . 1 2 ± 0 . 0 1 η β 5 
cycloheximide + 2.20 ± 1 . 4 0 21.6 ± 7 . 0 1.30 ± 0 . 4 0 0.63 ± 0 . 1 6 0.09 ± 0.02 5 
activity : lUDol/min.yg DNA 
ns : not signif icant Ρ > 0.01 
Table 3. Influence of cycloheximide on enzyme activity after 2 h adherene. 
G-6-PDH PHI ICDH NAG ACP η 
non-adherent 0.27 ± Ο.Οβ* 5.8 ± 1.7* 0.20 ± 0.15* 0.60 ± 0.27 0.0β ± 0.02 8 
adherent 2.03 ±0.68 17.9 ±3.6 1.18 ±0.22 0.66 ±0.11 0.10 ±0.02 β 
* Ρ < 0.01 
activity : nmol/min.ug DNA 
Table 4. Influence of adherence on enzyme activity after 2 h. 
N - ADH 51.3 ± 13.6 69.4 ± 14.6 
N - SUSP 32.9 ± 11.5* 70.8 ± 13.9 
BD - ADH 62.5 t 25.8 71.7 ± 21.7 
HD - SUSP 28.1 ± 17.1* 70.1 ± 9.9 
* Ρ < 0.01 
N - Normal 
HD • Hodgkin's Disease 
ADH · adherent 
SUSP • suepenaioD 
Activity : nmol/min.ug DNA 
Table 5. Enzyme activity after 15 days in both adherent and suspension 
cultures. 
91 
8.2 ± 3.2 
7.4 ± 3.5 
10.4 ± 4 
5.0 ± 2.9 
10.2 t 4.9 
14.3 ± 4.5 
11.9 1 5.2 
17.9 ± 8.5 
5.5 ± 3 
6.5 ± 2.7 
6.9 ± 2.8 
β.4 ± 5.7 
14 
11 
14 
11 
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Fig. 3. Changes in enzyme a c t i v i t y in 14 p a t i e n t s and 14 normal c o n t r o l s . 
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role аз circulating macrophage or Is Just an immature cell of the MPS, which 
displays a great variety of functions after extravascular maturation and/or 
activation. To evaluate the role of MPS in health and disease i t seems 
preferable to study the mature exponents of this system, however limited 
access to their anatomical s i tes in humans hampers this kind of work. An 
approach to overcome this limitation is the study of in vitro maturation of 
peripheral blood monocytes. This process of maturation i s extensively 
described using morphological, functional, enzyme and receptor a l terat ions 
as parameters 2>3f4i5,b,7,2 !_ j
n m o
g t studies monocytes adherent to plast ic, 
glass or coated surfaces were investigated. These monocytes were recovered 
from a mixed cel l suspension on the basis of their adherent properties, 
which implies selection and activation. 
In the present study we investigated the plastic-adherent capacity and 
subsequent maturation of CFC purified monocytes and compared those resul ts 
with the maturation process observed in suspension cultures. To our 
knowledge no information is available concerning a l terat ions in the 
intermediary metabolism during maturation. G-6-PDH activity was markedly 
increased (26 times), PHI and ICDH, on the other hand, showed much lesser 
changes (3 and 5 times respectively). This predominant increase in G-6-PDH 
activity indicates an enhanced HMPS glucose uti l izat ion and is most likely 
reflecting an augmented cellular need for NADPH and ribose-5-phosphate 
during maturation. 
A remarkable finding was the significantly lower G-6-PDH in the teflon grown 
macrophages after 15 days in comparison with the plastic-adherent ce l l s . 
Bodell et al " could demonstrate a rapid appearance of peroxidase activity 
in the rough endoplasmic reticulum after adherence. It was postulated that 
surface stimulation altered metabolic events. Our finding corroborates this 
supposition, although some influence of the differences in the culture 
conditions in our study cannot be excluded (bicarbonate buffered versus 
hepes buffered RPMI-1640, humidified atmosphere versus closed tubes). The 
observed a l terat ions in NAG and ACP are in accordance with the l i terature 
The differences in G-6-PDH, PHI and ICDH activity between adherent and non­
adherent monocytes after 2 h indicates a relationship between adherent 
capacity and intermediary metabolism. The fact that cycloheximide did not 
influence the 2 h enzyme levels makes denovo synthesis unlikely and points 
towards selection. The high recovery of teflon grown macrophages (88%) in 
comparison to the plastic-adherent (35$) implies that the non-adherent 
monocytes are likely to give r ise to mature macrophages. In preliminary 
experiments (data not shown) we could actually prove this, by growing mature 
macrophages in TCB from both adherent (after detachment) and non-adherent 
monocytes. 
After characterization of maturation in both suspension and adherent 
cultures we evaluated this process in Ή patients with predominantly 
advanced HD and 14 normal controls. It i s clearly shown in th i s study that, in 
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the presence of 10$ antologous serum, the differentiation from monocyte to 
macrophage in HD is undisturbed. The adherent capacity of the purified 
monocytes was for both groups identical. Measurement of the DNA content, 
instead of microscopical counting, fac i l i ta tes accurate quantitation of 
adherent cel ls . There are two earl ier reports describing, in contrast with 
our resul t s , low adherent cel l yield in patients with HD 23,24_ д
 0 ι 0 3 θ 
relat ionship was observed between a diminished PHA induced blastogenesis 
and a decreased number of adherent macrophages in unstimulated cultures in 
HD in comparison to normal controls ' . On the other hand Urbanità et al. ^5 
found a for HD and normal controls similar percentage of monocytes attached 
after 50 min. (26 and 24% respectively). In patients with solid tumours also 
a marked decrease in adherent macrophage yield was found after 7 days 
cul tunng ^т11,26,27, in
 a
i i studies mononuclear cel l suspensions, con­
taining monocytes, platelets and lymphocytes, were cultured in the presence 
of autologous serum. The non-adherent cel l s remained in culture. The 
influence of autologous serum factors was excluded in two studies and the 
existence of an intrinsic monocyte defect suggested 26,27, However, the 
maturation of non-adherent monocytes to macrophages as we could demon­
strate in our study, and the influence of non-adherent cells (direct or 
exerted by mediators) on both adherence and differentiation was not 
considered. Lymphokines of antigen stimulated lymphocytes promoted human 
monocyte adherence in vitro ''''»28, Musson and Henson 29
 0ould demonstrate 
and inhibition of monocyte adherence by plasma and serum factors which was 
counteracted by p late le ts . Lee et al. 30
 a
howed that interferon-1 can 
strongly inhibit monocyte maturation as measured with biochemical and 
morphological parameters. Except for the serum factors, a l l other influences 
were excluded in our study and permits therefore a more definite judgment 
concerning adherence and in vitro monocyte maturation. 
It was concluded that the in vitro monocyte differentiation was undisturbed 
in advanced HD, despite the well established presence of leukocyte function 
inhibiting serum factors. 31,32,32, This argues against an intr insic 
monocyte defect in HD. 
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CHAPTER 8 
LYSOZYME AND COLONY STIMULATING FACTOR SECRETION BY MONOCYTE DERIVED 
MACROPHAGES IN HODGKIN'S DISEASE 
P.H.M. de Mulder, J.M.C. Weasels, T. de Witte, E. van de Ven, A. van Erp and С. 
Haanen 
INTRODUCTION 
I t haa r e c e n t l y become e v i d e n t t h a t t h e macrophage had major s e c r e t o r y 
c a p a b i l i t i e s ^ . Known s e c r e t o r y products of mononuclear phagocytes a r e 
enzymes, enzyme i n h i b i t o r s , b inding p r o t e i n s , r e a c t i v e m e t a b o l i t e s of 
oxygen, n u c l e i c acid and m e t a b o l i t e s , b i o a c t i v e l i p i d s , growth f a c t o r s and 
endogenous pyrogens '. 
Lysozyme c o n s t i t u t e s t h e bulk s e c r e t o r y product of macrophages '»3, but i s 
a l s o p r e s e n t in t h e polymorponoclear l e u c o c y t e , however, i t i s not 
s y n t h e s i z e d by the l a t t e r , end s t a g e c e l l . 
Serum lysozyme l e v e l s were found to be i n c r e a s e d in p a t i e n t s with HD 5,°, 
This lysozyme appeared t o be p o s i t i v e l y c o r r e l a t e d with t h e s t a g e of the 
d i s e a s e and the p r e s e n c e of B-symptoms 5. A r e l a t i o n s h i p with tumor mass was 
sugges ted ' ' ' . Because i t has been shown t h a t monocyte-der ived macrophages 
produce and s e c r e t e lysozyme 3 | t h e s e c e l l s may be r e s p o n s i b l e for t h e 
e l e v a t e d serum l e v e l s observed in HD. Colony s t i m u l a t i n g fac tor (CSF) i s 
produced by a v a r i e t y of normal c e l l types i n c l u d i n g mononuclear phagocytes 
8,9,10 i T-Lymphocytes, and v a s c u l a r e n d o t h e l i a l c e l l s
 1 1
. Bes ides spon­
t a n e o u s r e l e a s e , a merked enhancement of CSF product ion can be i n i t i a t e d by 
endotoxin 9. Furthermore t h e mononuclear phagocyte seems to play an 
important ro le in the r e g u l a t i o n of CSF r e l e a s e by o t h e r c e l l t y p e s such a s 
T-lymphocytes and e n d o t h e l i a l c e l l s . 
•The aim of the p r e s e n t s tudy was the e v a l u a t i o n of some s e c r e t o r y p r o p e r t i e s 
of in v i t r o monocyte-derived macrophages a s parameter of t h e i r funct ion in 
p a t i e n t s with Hodgkin's d i s e a s e . Lysozyme and s p o n t a n e o u s colony s t i ­
mulating factor s e c r e t i o n were e v a l u a t e d in 12 and 10 p a t i e n t s r e s p e c t i v e l y . 
MATERIALS AND METHODS 
P a t i e n t s and c o n t r o l s 
Lysozyme a c t i v i t y was s t u d i e d in 12 p a t i e n t s , 4 women and 8 men, mean age 
42.2 ±,19 years (range: 19-73 y e a r s ) . The c l i n i c a l data are dep ic ted in Table 
1. Twelve heal thy v o l u n t e e r s e were used as c o n t r o l s (3 women, 9 men; mean 
age 31.5 + 7.1 years , r a n g e : 24-50 y e a r s ) . 
Colony s t imula t ing fac tor product ion was measured in 10 p a t i e n t s , 2 women 
and 8 men, age 28.1 + 6.6 y e a r s ( range: 21-42 y e a r s ) . Stage and pathology a re 
shown in Table 2. Seven h e a l t h y v o l u n t e e r s served a s c o n t r o l s (2 women and 5 
тел, mean age 22.6 ± 9.3 y e a r s ; range 22-33 y e a r s ) . The h i s t o l o g i c a l 
c l a s s i f i c a t i o n was a c c o r d i n g t o Lukes e t a l . 2 2 , s t a g i n g procedures were 
c a r r i e d out аз recommended a t the Ann Arbor conference 1 3 . 
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Stage 
IA 
IIA 
U I A 
H I B 
IVA 
3 
2 
1 
1 
3 
(1 NS, 2 MC) 
(2 MC) 
(NS) 
(MC) 
(2 NS, 1 MC) 
Table 1. Clinical data of HD patients tested for serum and monocyte lysozyme 
activity 
Stage 
HA 
IIB 
H I B 
IVA 
IVB 
η 
•i 
2 
2 
I 
2 
PA 
(2 MC, 3 NS) 
(NS, LP) 
(2 MC) 
(NS) 
(NS.MC) 
NS nodular sclerosis 
MC mixed cellularity 
LP lymphocytic predominance 
Table 2. Clinical data of HD patients tested for monocyte CSF production 
Monocyte isolation 
Monocytes were isolated by means of cel l scatter monitored counterflow 
centrifugation as described previously ^ » 1 5 , in both patients and normal 
controls an average purity of 89$ was obtained, representing 80% of al l 
elutriated monocytes. 
Monocyte-derived macrophage lymsozyme secretion 
Monocytes were cultured in hydrophobic teflon bags (TCB) according to Van 
der Meer et al. '". Freshly isolated monocytes were resuspended at a 
concentration of 3 x 105/ml in RPMI-1640 supplemented with 4mM glutamine, 
and 10$ autologous serum. Five ml of this cell suspension was gently 
injected into the TCB, and after diathermically sealing, cultured for 7 and 
15 days in a fully humidified atmosphere of 5$ 003 in air at 370C. At the end 
of the culture period, after gentle kneading of the TCB, the cell suspension 
was recovered, centnfuged (600 χ 9, 10 min, at 20oC) and the supernatant 
stored at -20oC for lysozyme measurements. 
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Lyaozyme аззау 
Lyaozyme activity was measured in both serum and culture supernatant, 
according to the method described by Prockop et al. 1". Enzyme activity was 
evaluated with a Beekman DB-G grating spectophotometer by measuring the 
decrease of turbidity, due to lysozyme induced desaggregation of the cell 
wall of the Micrococcus Lysodeickticus (Testomar-Lysozyme kit, Behring). 
Activity was expressed as mg human lysozyme/liter (Hl/1). 
Preparation of monocyte conditioned medium (MCM) 
Monocytes were cultured according to a modification of the method described 
о 
by Chervenick and Robuskio . After i s o l a t i o n , the monocytes were washed for 
10 mm, 400 χ 9 at 20 o C. Cel l s were resuspended in b i c a r b o n a t e buffered RPMI-
1640 (Boehnnger) supplemented with 20І (v/v) f o e t a l ca l f serum (PCS, Gibco) 
and 4mM glutamine (Flow) a t a c o n c e n t r a t i o n of 2 χ 10°/ml. Three ml of t h i s 
suspens ion was seeded in 50 ml p l a s t i c f l a s k s (Costar) and incubated a t 
370C for 7 days in a fully humidified atmosphere of 5$ COj in a i r . At the end 
of the cu l ture period the s u p e r n a t a n t was decanted, centr i fuged (10 min, 600 
χ 9 at 20oC) and a f t e r f i l t r a t i o n through a 0,45u f i l t e r (Millipore) s t o r e d a t 
-20 o C. 
Granulocyte-macrophage colony forming a s s a y 
In v i t ro cu l ture аззау,з w'fere performed as descr ibed prev ious ly . Brief ly : 
c u l t u r e s were done in 35 mm p l a s t i c p e t n d i s h e s (Costar) . Dulbecco's 
modified Eagles medium (Flow) was used with 20 % h e a t i n a c t i v a t e d FCS from a 
p r e s e l e c t e d batch in 0,3$ Bacto-agar (Difco). Nucleated c e l l s (2 χ 10^) were 
seeded with 10$ v/v. MCM obta ined from the v a r i o u s monocyte c u l t u r e s . All 
c u l t u r e s were done in d u p l i c a t e us ing the same normal bone marrow donor. As 
re fe rence source, CSF der ived from human p l a c e n t a condi t ioned in t h e 
presence of endotoxin was used. I n c u b a t i o n s were performed at 370C in a 
fully humidified atmosphere of 5$ CO2 in a i r for 10 days . Cultures were 
scored a t 20-40 χ magnif icat ion. Aggregates c o n s i s t i n g of 40 and more c e l l s 
were scored as c o l o n i e s , a g g r e g a t e s c o n s i s t i n g of < 40 c e l l s as c l u s t e r s , 
and < 20 c e l l s as small c l u s t e r s . 
Cell counting and d i f f e r e n t i a t i o n 
P e r i p h e r a l blood c e l l counts were performed with a Coulter counter model ZF. 
Cell d i f f e r e n t i a t i o n s were done on smears a f t e r s t a i n i n g for May-Grunwald-
Giemsa and by means of the Hemalog D (Technicon). 
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S t a t ì s t i c a 
The Wilcoxon two sample t e s t was used for s t a t i s t i c a l a n a l y s i s of the 
r e s u l t s . Numbers a re given a s mean ± s t andard dev i a t i on . 
RESULTS 
Lysozyme measurements 
Mean serum lysozyme a c t i v i t y in HD p a t i e n t s was s i g n i f i c a n t l y inc reased in 
comparison to normal con t ro l s (2.41 * 0.47 and 1.32 * 0.43 mg Hl/1 
r e s p e c t i v e l y ; ρ < 0.01). Mean r e l a t i v e and a b s o l u t e monocyte and granulo­
cyte numbers a re p r e s e n t e d in Table 3. The mean a b s o l u t e monocyte and 
granulocyte count in HD group was higher in comparison to t h e normal group, 
however t h e d i f f e r e n c e s were not s t a t i s t i c a l l y s i g n i f i c a n t (p < 0.05). A 
s i g n i f i c a n t p o s i t i v e c o r r e l a t i o n was found between t h e a b s o l u t e per iphera l 
blood g r a n y l o c y t e count and the serum lysozyme c o n t e n t (R: 0.47, ρ < 0.05). 
This was not observed between t h e monocyte count en serum lysozyme leve l . 
In a prel iminary experiment a lysozyme i n c r e a s e from 0.50 mg Hl/1 (t = 0) t o 
3.7 mg Hl/1 (t = 18 days) was found in t h e s u p e r n a t a n t of the moncyte 
c u l t u r e s . This r i s e of lysozyme was almost e x p o n e n t i a l . 
Lysozyme s e c r e t i o n by monocyte der ived macrophages form 12 p a t i e n t s with 
HD and 12 normal c o n t r o l s , e v a l u a t e d a t day 7 and 15 was not e s s e n t i a l l y 
d i f ferent (Table 3). 
CSF product ion by monocyte derived macrophages 
CSF a c t i v i t y of t h e s u p e r n a t a n t from 7 days cul tured pur i f ied monocytes was 
measured in 10 p a t i e n t s with predominantly asymptomatic HD. The r e s u l t s are 
shown in Table 4. Both the number of c o l o n i e s and c l u s t e r s obta ined with the 
MCM from p a t i e n t s with HD tended to be lower, however the d i f fe rences were 
not s t a t i s t i c a l l y s i g n i f i c a n t (p > 0.05). 
DISCUSSION 
Serum lysozyme in t h e HD group was s i g n i f i c a n t l y i n c r e a s e d in comparison to 
the normal c o n t r o l group. This i s in agreement with e a r l i e r o b s e r v a t i o n s 5,6. 
No s i g n i f i c a n t c o r r e l a t i o n was found with t h e a b s o l u t e number of c i r c u l a t i n g 
monocytes which c o r r o b o r a t e s t h e f inding of Corberand e t a l . . The a b s o l u t e 
g ranulocyte number showed a moderate, but s t a t i s t i c a l l y s i g n i f i c a n t 
c o r r e l a t i o n with the serum lysozyme l e v e l of the whole group s t u d i e d . Hansen 
e t a l . c u found a s t rong c o r r e l a t i o n between both g r a n u l o c y t e turnover and 
t o t a l blood g r a n u l o c y t e pool, and serum lysozyme a c t i v i t y (H: 0.88 and R 0.81 
r e s p e c t i v e l y ) . In t h e p r e s e n t study t h e monocyte der ived macrophages of 
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HD normal controls 
Relative monocyte count (Ζ) 
Absolute monocyte count/ran3 
Relative granulocyte count (Z) 
Absolute granulocyte count/nm1 
Serum lysozyme mg Hl/1 
7 days supernatant lysozyme 
15 days supernatant lysozyme 
* ρ < 0.01 
Table 3. The granulocyte and monocyte values in the peripheral blood 12 
patients with HD and 12 normal controls. Results of lysozyme 
measurements. 
colonies c lusters 
< 20 < 40 
without supernatant 0 0 0 
placenta CSF 83 41 41 
mono-supernatant normals 5.6 ± 7.3 137.1 ± 41.5 93 ± 47 
mono-supernatant HD 2.8 ± 4 134 ± 73 55 ± 49 
Table 4. Results of CSF production by 7 days cultured monocytes in 10 
patients with HD and 7 normal controls. 
both groups secreted almost indentical amounts of lysozyme measured at two 
different time intervals. One should realize that no information is available 
concerning the monocyte t ransi t time in the peripheral blood compartment 
and that the absolute blood monocyte number is not only reflecting turnover. 
The possibility that an increased macrophage mass in HD may account for the 
observed elevated serum lysozyme levels in not excluded. Our observations 
on monocyte-derived macrophages makes i t unlikely that the elevated serum 
lysozyme level is due to an increased production by single macrophages, 
which i s in agreement with a studies in other malignancies 2 1 . 
The mononuclear phagocyte system plays an important modulatng role in 
hematopoiesis by releasing CSF and other factors which stimulate CSF 
production by other cell types 11122,23, Moore et a l . 2 2 observed a close 
positive correlation between monocyte number in the peripheral blood and 
detectable CSF activity in the serum of a cyclic neutropenic patient. 
6.4 ± 3.8 
474 ± 205 
66.2 ± 12.9 
5638 ± 2807 
2.41 ± 0.47* 
0.98 ± 0.27 
2.58 ± 0.66 
5.5 ± 1.8 
377 ± 155 
52.3 ± 11.5 
3723 ± 1720 
1.32 ± 0.43 
0.96 ± 0.19 
2.40 ± 1.05 
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Besides stimulatory factors, monocytes release inhibitors of hematopoiesis, 
such as prostaglandin E2 10>24>25# p o r these reasons MCM contains 
stimulators and inhibitors and in fact a netto effect is evaluated. The MCM 
in our study induced much less colonies than optimal CSF obtained from 
human placenta. The resul ts with MCM of 10 predominantly asymptomatic 
patients with HD indicate a lower mean number of colonies and clusters in 
comparison to 7 normal controls, however the differences were not s t a t i s t i -
cally significant. Monocyte PGEo production has been shown to be increased 
in HD patients " . This might in part explain the observed tendency of 
diminished CSF activity of MCM in the present study. 
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CHAPTER 9 
SUMMARY AND GENERAL CONCLUSIONS 
Chapter 1 presents a short introduction and an outline of the in-
vest igat ions. 
Chapter 2 reviews the function of the mononuclear phagocyte system (MPS) in 
the pathophysiology of Hodgkin's disease (HD). Few studies are available 
dealing with the function of the t issue macrophages. All the studies on 
monocyte function described in this review, were performed either on mixed 
cel l populations or adherent monocytes. 
So far no specific alteration in the MPS function could be demonstrated in 
HD. 
In chapter 3 a new method for monocyte isolation has been described. 
Continuous monitoring of cel l light scatter during counterflow c e n t n -
fugation allowed counting and size recognition of the ce l ls . For each donor 
an optimal separation point between lymphocytes and monocytes could be 
determined, resulting in a monocyte purity of more than 90$, with 84$ of al l 
elutriated monocytes present in this enriched fraction. The cell recovery 
after e lu tna t ion (or counterflow centnfugation) was 90$ and the viability 
was excellent. 
In chapter k the resul ts of antibody-dependent cel lular cytotoxicity 
mediated by purified monocytes (MO-ADCC) have been presented. A new and 
sensi t ive ADCC assay was used, avoiding time consuming labeling techni-
ques. The method is based on the difference in DNA content between the 
chicken red blood cel l (CRBC) target and the monocyte effector cel l . 
Analysis was performed by means of DNA flow cytometry. In HD a significantly 
increased MO-ADCC was found in comparison to normal controls. No cor-
relation was found between the absolute monocyte number in the peripheral 
blood and the level of MO-ADCC. This argues against a shift in functionally 
different monocytes on the basis of monocytosis, which was present in 50$ of 
the patients studied. There was no relation with the stage of the disease; 
however, in patients with B-symptoms MO-ADCC tended to be higher than in the 
asymptomatic group. 
Chapter 5 outlined the resul ts of MO-ADCC in a group of patients with HD in 
remission, a group with non-Hodgkin lymphomas, and a group with solid 
tumors. MO-ADCC appeared to be significantly increased in both non-Hodgkin 
lymphomas and patients with solid tumors. MO-ADCC was established to be 
normal in patiens with HD in complete remission. Furthermore the monocyte 
appeared to be a more potent effector cell towards CRBC than concomitantly 
isolated lymphocytes. 
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In chapter 6 the resul ts of intracel lular enzyme analyses of monocytes 
obtained from HD patients and normal controls, this is compatible with an 
enhanced function of the hexose monophosphate shunt, and reports of 
increased glucose uti l ization through this shunt after activation. 
Monocyte maturation was studied in HD patients and normal controls using 
adherent and non-adherent (suspension) culture conditions. Cell growth was 
evaluated by measuring the intracel lular content of two acid hydrolases, and 
glucose uti l ization by measuring 3 enzymes of intermediary metabolism. The 
resul ts are presented in chapter 7. 
The yield of macrophages after 15 days in the non-adherent cultures was 
69%, in contrast to 35$ in the adherent cultures. After 2 hours, monocyte 
adherence was accompanied by a significantly higher acitvity of 3 enzymes 
of intermediary metabolism, in comparison to the activity in non-adherent 
monocytes 
Monocyte maturation in both adherent and in suspension cultures was 
undisturbed in HD. The adherent capacity of monocytes from HD patients 
appeared to be comparable with normal control monocytes. 
In chapter 8 the results of some secretional properties of monocyte derived 
macrophages have been reported. Lysozyme secretion by macrophages from 
patients with HD, measured at two time intervals , was comparable to that 
observed in normal controls. On the other hand serum lysozyme activity was 
significantly increased in HD patients . No correlation with the absolute 
monocyte number in the peripheral blood was found, the elevated serum 
lysozyme level might be due either to an augmented granulocyte turnover, or 
related to an increased mass of MPS in HD. 
Colony stimulating factor activity in the supernatant of 7 days cultured 
monocytes tended to be lower in HD patients in comparison to normal 
controls. 
Till now al l studies on monocytes have been performed on unseparated or 
functionally selected ce l ls . In our study atraumatically purified monocytes 
have been used with only minimal selection and avoiding activation, and the 
results are therefore more representative for the circulating blood 
monocyte. The separation procedure was, thanks to the cel l recognition 
device, very reproducible and well applicable to the purification of 
monocytes from patients mononuclear cell suspensions. The advantage of 
this isolation method is once more emphasized by the finding that monocytes 
are heterogeneous in their adherent capacity, and that prolonged adherence 
coincides with hexose monophosphate shunt activation. 
Both our findings on effector function activity and intermediary metabolism 
are in accordance with a higher activity of monocytes obtained from patients 
with HD. The increased effector function was related with overt disease, but 
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also present in patients with non-Hodgkin lymphomas and solid tumors. 
Monocyte maturation and adherent capacity in HD was normal, which is in 
contrast with reports by investigators using mixed cell populations. 
Lysozyme production by in vitro grown macrophages also indicated a normal 
function in HD. The measured activity of colony stimulating factor in the 
supernatant is in fact the result of a balance between stimulators and 
inhibitors, both produced by monocytes and macrophages. 
The suppression of lymphocyte proliferation by monocytes from patients with 
HD, described in the l i terature , is not in contrast with our findings of an 
activated monocyte function, in view of the known higher suppressive 
capabi l i t ies of monocytes after activation. 
In conclusion, the monocyte appears to be functionally intact in patients 
with HD. The number of monocytes in HD is frequently elevated and their 
function appears to be enhanced. These al terat ions are related with overt 
disease, but HD specificity could not be demonstrated. 
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ALGEMENE SAMENVATTING 
De z i e k t e van Hodgkin і з een b i jzondere vorm van kwaadaardige lymfeklier 
z i e k t e , die voor het e e r s t werd beschreven door Thomas Hodgkin in 1832. Pas 
de laats te 15-20 jaar is er enig inzicht verkregen omtrent de aard en de 
oorzaak van deze ziekte, die zonder behandeling, fataal verloopt. Veel 
aandacht is besteed aan de bij patiënten met de ziekte van Hodgkin zo 
opvallend verhoogde gevoeligheid voor virale en mycotische infecties. Met 
name werd veel onderzoek verricht naar de mogelijke rol van de lymfocyt in 
dit immunologische defect. 
Recent i s ook belangstelling ontstaan voor de betekenis van het mono-
nucleair fagocyterend systeem (MPS) in de pathofyslologie van de ziekte van 
Hodgkin. Het MPS bestaat uit voorloper cellen in het beenmerg, die uitgroeien 
tot de monocyten in het perifere bloed en vervolgens uitrijpen tot een grote 
verscheidenheid aan weefsel macrofagen. Het MPS speelt een belangrijke rol 
bij het opruimen van afstervende cellen en bij het ontstaan en effectueren 
van afweer react ies , verder worden zeer veel stoffen geproduceerd en 
uitgescheiden, die betrokken zijn bij talr i jke biologische processen, welke 
onder meer samenhangen met proliferatie en maturatie van cellen. 
In Hoofstuk 1 wordt een kort overzicht gegeven van het doel en werkplan van 
de studie. Het onderzoek van het MPS is geconcentreerd op de relatief 
eenvoudig te verkrijgen bloed monocyt. 
Hoofdstuk 2 gaat in op de in de li teratuur vermelde waarnemingen betreffende 
de functie van het MPS bij de ziekte van Hodgkin. Er is tot nu toe geen voor 
de ziekte kenmerkende afwijking in de functie van het MPS vastgesteld. Het 
overgrote deel van deze onderzoekingen is gedaan met onzuivere cel 
populaties (lymfocyten en monocyten) en slechts enkele met gezuiverde 
monocyten. Deze laa ts te waren echter niet aselect ief verkregen, aangezien 
de zuiveringsmethode berustte op de adhererende eigenschap van de monocyt. 
Over de functie van macrofagen is weinig bekend, daar deze niet in voldoende 
mate intact voor onderzoek te verkrijgen zijn. 
Gezien het ontbreken van onderzoek met aselect ief gezuiverde monocyten bij 
de ziekte van Hodgkin werd een nieuwe isola t ie methode ontwikkeld, waarmee 
monocyten kunnen worden verkregen met een hoge zuiverheid (90$), met een 
goede opbrengst (84?) en viabi l i te i t (98 ï ) . De scheiding vindt plaats met 
behulp van een tegenstroom centrifuge, gekoppeld aan een systeem dat de 
grootte van de cel continue kan bepalen. Op deze manier kan voor iedere 
donor het optimale scheidingspunt tussen lymfocyten en monocyten worden 
vastgesteld (Hoofdstuk 3). 
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Ala belangrijke effector functie werd het antilichaam afhankelijke cel 
dodende vermogen van de monocyt onderzocht (MO-ADCC) (Hoofstuk 4). 
Voor het meten van deze functie werd een nieuwe en gevoelige methode 
gebruikt, gebaseerd op het verschil in DNA gehalte tussen de kippe rode 
bloed cellen (CRBC) en de monocyten. De cel-dood, gemeten aan verlies van 
het DNA-gehalte van de met antilichaam gecoate CRBC, geschiedde met behulp 
van DNA- flowcytometrie. Bij patiënten met de ziekte van Hodgkin bleek de 
MO-ADCC significant hoger te zijn dan bij de normale controle groep. Er werd 
geen correlatie gevonden tussen het absolute aantal monocyten in het 
peripere bloed en het percentage celdood. Dit pleit tegen een eventuele 
functieverandering tengevolge van een toegenomen aantal monocyten in het 
bloed. In 50$ van de onderzochte patiënten werd een absolute monocytose 
gevonden. Er was geen re la t ie met het stadium van de ziekte en de hoogte van 
de MO-ADCC; patiënten met B-symptomen tendeerden echter tot een hogere MO-
ADCC dan de asymptomatische patiënten. 
Hoofdstuk 5 bevat de resultaten van MO-ADCC van een groep patiënten met de 
ziekte van Hodgkin na het bereiken van een complete remissie /van een groep 
met een non-Hodgkin lymfoom en van patiënten met een solide tumor. Zowel bij 
patiënten met een non-Hodgkin lymfoom als bij patiënten met een solide 
tumor werd een significant verhoogde MO-ADCC gevonden. Bij patiënten, die 
met goed resultaat behandeld waren voor de ziekte van Hodgkin bleek de MO-
ADCC in het normale gebied te liggen. Deze resultaten geven aan dat de 
verhoogde monocyten ac t iv i te i t bij een grote verscheidenheid van kwaad-
aardige ziekten aanwezig i s , en na effectieve behandeling, zoals aangetoond 
bij de ziekte van Hodgkin, normaliseert. 
Hoewel de lymfocyt ook effectief een ADCC tot expressie kan brengen in het 
gebruikte testsysteem, bleek dit vermogen bij de monocyt in alle onder-
zochte gevallen sterker. 
Een andere manier om de eventueel verhoogde ac t iv i te i t van de monocyt bij 
de ziekte van Hogkin aan te tonen is de bestudering van enige metabole 
aspecten. Dit is weergegeven in Hoofstuk 6. 
Monocyten van patiënten met de ziekte van Hodgkin bleken een significant 
hogere glucose-ö-fosfaat dehydrogenase (G-6-PDH) ac t iv i te i t te vertonen in 
vergelijking met monocyten van een normale controle groep. Dit past bij een 
act ivat ie van de hexose monofosfaat shunt. In de l i teratuur is beschreven 
dat de metabolisering van glucose door deze shunt toeneemt indien 
monocyten en macrofagen gestimuleerd worden door bijvoorbeeld lymfokinen. 
De monocyt groeit na het verlaten van de bloedbaan, in de weefsels uit tot 
macrofaag en ondergaat tijdens dit proces een groot aantal veranderingen. 
In Hoofdstuk 7 zijn de karakteristieken van de twee gebruikte in vitro 
kweekmethoden aangegeven en wordt het ui tnjpingsproces van monocyten van 
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patiënten met de ziekte van Hodgkin en van normale controle personen 
beschreven. Monooyten werden zowel adherent (vastgehecht aan plast ic) als 
non-adherent (in teflon) gekweekt. De opbrengst aan adhérente macrofagen 
na 15 dagen was 35$ in vergelijking tot 89ï voor de non-adherent 
gekweekte. Deze laa ts te hadden na 15 dagen een significant lagere G-6-PDH 
act iv i te i t dan de adherent gekweekte macrofagen, hetgeen wijst op s t i -
mulatie en se lect ie door de hechting aan plas t ic . 
De monocyten, die na 2 uur niet hechtten, bleken een beduidend lager glucose 
metabolisme te bezitten in vergelijking met de monocyten die dit vermogen 
wel bezaten. 
Het ui tnjpings proces, vervolgd aan de hand van 2 lysozomale enzymen, 
bleek voor monocyten van patiënten met de ziekte van Hodgkin vergelijkbaar 
met dat van normale monocyten. Het vermogen tot hechten was voor beide 
groepen eveneens gelijk. Deze bevindingen wijkt af van de waarnemingen 
beschreven in de literatuur, waarbij de ui tnjping van de adhérente 
monocyten afkomstig van patiënten met solide tumoren sterk verminderd zou 
zijn. 
De resultaten betreffende de uitscheiding van lysozyme en kolonie s t i -
mulerende ac t iv i te i t door in vitro gekweekte macrofagen worden beschreven 
in Hoofdstuk 8. 
De lysozyme uitscheiding gemeten op 2 tijdstippen bleek voor patiënten met 
de ziekte van Hodgkin en normalen gelijk. Het serum lysozyme gehalte was 
echter aanzienlijk hoger bij Hodgkin patiënten dan bij normale controle 
personen. Er werd geen correlatie gevonden met het absolute aantal 
monocyten in het perifere bloed. Het verhoogde lysozyme gehalte in het 
serum kan afkomstig zjn van een verhoogde granulocyten turnover of 
samenhangen met een toegenomen massa van het MPS. Over dit laats te aspect 
zijn echter geen gegevens beschikbaar. De kolonie stimulerende ac t iv i te i t 
in het kweek supernatant bleek bij patiënten met de ziekte van Hodgkin wat 
lager dan bij de normale controle groep. 
Alle tot nu toe in de l i teratuur beschreven onderzoeken betreffende de 
monocyten functie bij patiënten met de ziekte van Hodgkin zijn verricht met 
niet gezuiverde monocyten, waardoor interact ie met andere cellen niet kon 
worden uitgesloten, evenmin als functie veranderingen ten gevolge van de op 
adherentie gebaseerde isolat ie methode. In tegenstelling daarmee zijn de 
hier beschreven waarnemingen verricht met atraumatisch gezuiverde mono-
cyten, waarbij de select ie minimaal was en activering door bijvoorbeeld 
hechten is vermeden. De verkregen gegevens mogen daarom ook als meer 
representatief voor de perifere bloed monocyt beschouwd worden. De 
scheidingsprocedure i s , dankzij het cel herkenningssysteem, zeer repro-
duceerbaar. 
Het voordeel wordt geaccentueerd door de waarneming dat de monocyten 
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heterogeen zijn ten aanzien van hun vermogen zich te hechten aan vreemde 
oppervlakken en het feit dat z i j door dit laa ts te metabool geactiveerd 
worden. 
Zowel de toegenomen effector functie (ADCC) als de gevonden verandering in 
het intermediaire metabolisme passen bij een toegenomen act ivi te i t van de 
monocyt bij de ziekte van Hodgkin. Deze toeneming li jkt samen te hangen met 
de aanwezigheid van de ziekte, maar is eveneens aantoonbaar bij patiënten 
met een non- Hodgkin lymfoom en patiënten met een solide tumor. Dit wijst op 
een waarschijnlijk aspecifieke beïnvloeding van de monocyten functie door 
dergelijke aandoeningen. De in vitro monocyten ui tnjping was ongestoord 
hetgeen een belangrijk argument voor normaal funktioneren is . De gevonden 
lysozyme productie door in vitro gekweekte raacrofagen wijst eveneens in die 
richting. De licht verlaagde kolonie stimulerende ac t iv i te i t is in feite het 
resul taa t van zowel stimulatoren als remmers, welke beide door de monocyt/ 
macrofaag worden geproduceerd. De in de l i teratuur beschreven onder-
drukking van de lymfocyten proliferatie door de monocyt, ia niet strijdig met 
onze resultaten, die wijzen op een geactiveerde functie. Het is namelijk 
bekend dat de suppressieve eigenschappen van de monocyt toenemen na 
stimulatie. 
Samenvattend blijkt uit dit onderzoek dat de monocyt bij de ziekte van 
Hodgkin functioneel intact i s , maar dat veelal zowel het aantal als hun 
ac t iv i te i t is toegenomen. Deze quantitatieve en qualitatieve veranderingen 
van monocyten hangen samen met het manifest zijn van de ziekte, maar is als 
zodanig met specifiek voor de ziekte van Hodgkin. 
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gehe le onderzoek per iode voor d i t onderdee l a l s een onmisbare ' t r oub le 
shoote r ' i s opget reden . 
Voor de u i tvoe r ing van de vele sche id ingen , k leur ingen en bepal ingen heb ik 
dage l i j k s mogen samenwerken met Erik van de Ven en in de beginfase met 
Gerdien R o s e n b r a n d . Arie Pennings was behulpzaam met het opze t t en van 
c y t o t o x i c i t e i t s t e s t en Jan van Egmond ontwikkelde het j u i s t e computer 
programma. 
Manet Hi l legers -Ewals maakte de vele honderden l i t e r s buffer nodig voor 
de e l u t r i a t o r experimenten. 
Vruchtbaar was de samenwerking met de werkgroep Biochemie van de a fde l ing 
Dermatologie (hoofd P.D. Mier, Ph D), alwaar Helga van Rennes op i n v e n t i e v e 
en a c c u r a t e wijze de ve le enzym bepal ingen v e r i c h t t e en Mieke Bergers 
behulpzaam was b i j de s t a r t van de monocyten kweek. Aan de p a t i ë n t e n en de 
vele normale proefpersonen, die be lange loos hun medewerking ver leenden , 
ben ik vee l dank verschu ld ingd . 
De medewerking van ve le co l l egae in de regio was, voor het verkr i jgen van 
voldoende p a t i ë n t e n , onon tbeer l i jk . Met name wil ik noemen Drs. G. Boe t ius , 
Dr. W. Breed, Dr. F. van Dam, Drs. A. Dolman, Drs. G. Hoogendoorn, Drs. L. 
Eekhout, Dr. R. Kurst jens , Drs. H. Scheerder en Drs. J. S teenbergen . 
De afdel ing medische fo tograf ie (hoofd: A. Reijnen) was behulpzaam met het 
drukklaar maken van de t a b e l l e n , fo to ' s en de omslag. Paul Mier vond s t e e d s 
t i j d voor het b i j schaven van het Engels en de l a a t s t e k r i t i s c h e en 
nauwgezette c o r r e c t i e van het manuscript gesch iedde door de heer J. de Pauw. 
De heer de Graaff en zi jn medewerkers waren a l t i j d zeer behulpzaam bi j het 
verzamelen van de l i t e r a t u u r . 
Angela van den Broek en Loes Baadenhuijsen verzorgden op deskundige en 
geautomat i seerde wijze het typewerk en drukklaar maken van het manuscr ipt . 
Marjan Janssen verzorgde de t a b e l l e n . 
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Curriculum vitae 
De auteur van dit proefschrift werd geboren op 28 mei 1949 te Heerlen. In 
1967 werd het eindexamen HBS-B behaald op het St.Dominicus College te 
Nijmegen. Aansluitend studeerde hij geneeskunde aan de Katholieke Univer-
siteit te Nijmegen. In 1971 was hij 3 maanden werkzaam als Extern in het 
Somerset Hospital, Somerville, New Jersey, USA. 
Het doctoraal examen werd in 1973 en het artsexamen in 1975 behaald. De 
dienstplicht werd vervuld, als bataljon's arts bij de Koninklijke Land-
macht. In 1976 werd begonnen met de opleiding tot internist aan de 
Universiteits Kliniek voor Inwendige ziekten te Nijmegen (hoofd destijds 
Prof.dr.C.L.H. Majoor t en sinds januari 1980 Prof.dr.A. van 't Laar). 
Medio 1979 werd gestart met het onderzoek (KWF-subsidie NUKC 79-10) op de 
afdeling Bloedziekten ( hoofd Prof.dr.C.Haanen). In de toekomst zal hij 
werkzaam zijn op de afdeling Medische Oncologie ( hoofd Prof.dr.D.J.Th. 
Wagener). 
Hij is getrouwd met Willemien Hertens en zij hebben een zoon, Huib. 
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Stellingen 
behorende bij het proefschrift van 
P.H.M. de Mulder 
ι 
Voor de bestudering van eigenschappen van een specifieke celpopulatie is een aselectieve 
en atraumatische celscheiding een essentiële voorwaarde. 
Dit proefschrift. 
II 
Reproduceerbare scheiding van mononucléaire celsuspensies, bestaande uit per donor 
variabele aantallen trombocyten, lymfocyten en monocyten, is optimaal mogelijk met 
behulp van tegenstroom centrifugatie, indien de uitstroom, met behulp van lichtver-
strooiing, continu op celaantal en grootte geanalyseerd wordt. 
Dit proefschrift. 
III 
De hexose-monofosfaatshunt activiteit, de maturatie, de lysozyme secretie en de anti-
lichaam afhankelijke cytotoxiciteit van monocyten van patiënten met de ziekte van 
Hodgkin is normaal tot toegenomen. Bij patiënten met een non-Hodgkin lymfoom of 
solide tumor wordt eveneens frequent een verhoogd cytotoxisch vermogen gevonden. 
Dit proefschrift. 
IV 
Adhérente macrofagen representeren niet het totale aantal precursors (monocyten) in 
het perifere bloed. 
Dit proefschrift. 
V 
Monocyten zijn functioneel te onderscheiden op basis van hun adhererend vermogen. 
Parallel hiermee blijkt het glucose metsbolisme veranderd. 
Dit proefschrift. 
VI 
De aanwezigheid van dermatopatische lymfadenopathie bij patiënten met een T-cel 
lymfoon van de huid moet als uiting van generalisatie worden beschouwd. Men dient 
naast locale behandeling een systemische therapie te overwegen. 
Bunn P.A., Huberman M.S., Whang-Peng J. et al., Prospective staging evaluation 
of patients with cutaneous T-cell lymphonas. Demonstration of a high frequency 
of extracutaneous dissemination.Ann. Intern. Med. 1980; 93: 223. 
VII 
Interval-verlenging tussen de cytostatische kuren bij de behandeling van de ziekte van 
Hodgkin en non-Hodgkin lymfomen vermindert de kans op het bereiken van een com-
plete remissie. Uitstel op andere gronden dan een beperkte beenmerg tolerantie moet 
daarom vermeden worden. 
Vili 
Voor de prognose van patiënten met een non-Hodgkin lymfoom is het histologisch 
beeld meer indicatief dan het stadium. 
IX 
Indien bij een patiënt met een gesupprimeerd immunologisch systeem neurologische 
symptomen ontstaan, moet de goed behandelbare Toxoplasma Gondii infectie van het 
centrale zenuwstelsel overwogen worden, en bij de uitsluiting van duidelijke andere 
oorzaken dient de patiënt als zodanig behandeld te worden. 
Townsend J.J., Wolinsky J.S.,Baringei J.R., Johnson P.C. .Acquired toxoplasmosis. 
Λ neglected cause of treatable nervous system disease. Arch. Neurol. 1975; 32: 335. 
Eigen waarneming. 
Χ 
Bij 'idiopathisch' hypoproteinemisch oedeem op basis van een hypertrofische gastritis 
(ziekte van Ménétrier) kan een spontaan herstel van het serum eiwitgehalte gezien wor-
den. Het verdient daarom aanbeveling, indien voor deze indicatie een maagoppervlak 
verkleinende operatie wordt overwogen, een afwachtende houding aan te nemen. 
XI 
De spontane in vitro groei van burst forming units uit geaspireerd beenmerg is het beste 
diagnostische criterium voor een polycythemia vera. 
Lacombe С , Cadaderall Ν., Vaiet В., Polycythemia vera: in vitro studies of circu­
lating erythroid progenitors. Br. J. Haematol 1980; 44: 189. 
Th. de Witte, persoonlijke mededeling. 
XII 
Hematoporfyrine derivaten (HPD) vormen, onder invloed van licht, sterk cytotoxische 
zuurstof radicalen. Door de gevonden verhoogde retentie van HPD in maligne en pré-
maligne weefsels lijkt 'fototherapie' een nieuwe en beloftevolle behandelingsmodaliteit 
tegen kanker te kunnen worden. 
Dougherty IJ., Grindcy G.B., Fiel R. et al.. Photoradiation therapy: II cure of 
animal tumors with haematoporhyrin and light. J.Nat. Cancerlnst. 1975; 55: 115. 
Forbes I.J., Cowled P.A., Leong A.S.Y. et al., Phototherapy of human tumours 
using haematoporphyrin derivative. Med. J. Aust. 1980; 2: 489. 
XIII 
Het ontbreken van een citatie index voor universitaire onderwijs activiteiten komt de 
prioriteit die dit onderwijs verdient niet ten goede. 
XIV 
Het zou aanbeveling verdienen tenminste één van de maatschappijvakken voor het eind-
examen in het voortgezet onderwijs verplicht te stellen. 
XV 
Inhoudelijk wordt op de arts-patiëntrelatie vooral een beroep gedaan als het medisch 
technische resultaat niet aan de verwachtingen beantwoordt. 
Nijmegen, 10 juni 1983 P.H.M. de Mulder 

